TABLE OF CONTENTS
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No.  )
Filed by the Registrant
Filed by a Party other than the Registrant
Check the appropriate box:
Preliminary Proxy Statement
CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material under §.240.14a-12
Diversified Healthcare Trust
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

TABLE OF CONTENTS
Notice of 2024 Annual Meeting
of Shareholders and Proxy Statement
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
Friday, May 31, 2024 at 9:30 a.m., Eastern time
Live Webcast Accessible at
https://www.virtualshareholdermeeting.com/DHC2024
 

TABLE OF CONTENTS
[MISSING IMAGE: pg_business-4c.jpg]

TABLE OF CONTENTS
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
LETTER TO OUR SHAREHOLDERS
FROM YOUR BOARD OF TRUSTEES
[MISSING IMAGE: ph_boardtrustees-4clr.jpg]
Dear Fellow Shareholders:
Please join us for our 2024 Annual Meeting of Shareholders, which will be held virtually at 9:30 a.m., on Friday, May 31, 2024. The business to be conducted at the meeting is explained in the attached Notice of Meeting and Proxy Statement. We believe furnishing these materials over the internet expedites your receipt of these important materials while reducing the cost and environmental impact of our annual meeting.
2023 was a pivotal year for DHC as we made significant progress improving operational performance across our portfolio, contributing to a full year 2023 increase to Normalized FFO of 207% to $41.1 million. Throughout the year, we refreshed or fully renovated 65 of our SHOP communities in addition to other projects across our SHOP communities for a total cost of $183 million. We expect the completed projects will serve as a bridge to occupancy and NOI growth in 2024 and beyond and contributed to our 2023 Cash Basis NOI increase to $236.2 million, a 43% increase over the prior year. We ended the fourth quarter with SHOP occupancy of 79.3%, an increase of 300 basis points and an average monthly rate increase of 5.5% year over year. We also began to transition 13 non-performing communities to a different operating partner with the goal of improving performance.
In December, we took a meaningful step forward to support our growth with the issuance of $940.5 million of zero coupon senior secured notes. We used the proceeds to repay in full all of our $700 million of outstanding debt maturing in 2024. As a result of the bond issuance and repayments, we also regained debt covenant compliance.
During 2023, we sold 8 non-core properties that were located in markets where we believe that there is minimal NOI growth potential or required excessive capital investment. Total proceeds from these sales were $18.9 million.
With respect to our medical office and life science assets, in 2023, we executed 886,000 square feet of leases with an average rent rollup of 11.1%. We are actively marketing properties with vacancies and upcoming expirations.
We continue to monitor changing events and circumstances with an eye to managing for the global good, mitigating the negative impact on our business and best positioning us for stability and recovery. We take seriously our role in the oversight of our Company’s long term business strategy, which we believe is the best path to long term value creation for our shareholders.
We thank you for your investment in our Company and for the trust you place in us to oversee your interests in our business.
March 26, 2024
Jennifer F. Francis
Phyllis M. Hollis
John L. Harrington
Adam D. Portnoy
Lisa Harris Jones
Jeffrey P. Somers
 

TABLE OF CONTENTS
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
NOTICE OF 2024 ANNUAL MEETING OF SHAREHOLDERS OF DIVERSIFIED HEALTHCARE TRUST
Location:
Live Webcast Accessible at
https://www.virtual
shareholdermeeting.com/

DHC2024
Date:
Friday, May 31, 2024
Time:
9:30 a.m., Eastern time
Agenda:

Elect the Trustee nominees identified in the accompanying Proxy Statement to our Board of Trustees;

Advisory vote to approve executive compensation;

Ratify the appointment of Deloitte & Touche LLP as our independent auditors to serve for the 2024 fiscal year; and

Transact such other business as may properly come before the meeting and at any postponements or adjournments of the meeting.
Record Date: You can vote if you were a shareholder of record as of the close of business on March 22, 2024 (the “Record Date”).
Attending Our 2024 Annual Meeting: To provide all of our shareholders an opportunity to participate in our 2024 Annual Meeting, our 2024 Annual Meeting will be a completely virtual meeting of shareholders which will be conducted exclusively by webcast. Shareholders will be able to listen, vote and submit questions during our 2024 Annual Meeting. In order to attend and participate in our 2024 Annual Meeting, shareholders must register in advance at www.proxyvote.com by 11:59 p.m. Eastern time, on May 30, 2024.

Record Owners: If you are a shareholder as of the close of business on the Record Date who holds shares directly, you may participate in our 2024 Annual Meeting by visiting https://www.virtualshareholdermeeting.com/DHC2024 and entering the 16 digit control number located on your Notice Regarding the Availability of Proxy Materials or proxy card.

Beneficial Owners: If you are a shareholder as of the close of business on the Record Date who holds shares indirectly through a brokerage firm, bank or other nominee, you may participate in our 2024 Annual Meeting by visiting https://www.virtualshareholdermeeting.com/DHC2024 and entering the 16 digit control number located on your Notice Regarding the Availability of Proxy Materials, proxy card or voting instruction form. Please follow the instructions from your bank, broker or nominee included with these proxy materials, or contact your bank, broker or nominee to request a control number if needed.
Please see the accompanying Proxy Statement for additional information.
By Order of our Board of Trustees,
[MISSING IMAGE: sg_jenniferclark-pn.jpg]
Jennifer B. Clark
Secretary
March 26, 2024
 

TABLE OF CONTENTS
TABLE OF CONTENTS
1
2
4
4
4
4
5
6
6
18
18
19
20
20
20
21
21
21
22
22
22
22
24
25
27
34
35
35
35
35
36
36
36
36
37
38
38
39
41
42
42
45
45
45
47
47
47
48
 

TABLE OF CONTENTS
48
49
49
50
50
50
51
54
54
55
55
56
57
62
63
A-1
PROXY STATEMENT
The Board of Trustees (our “Board”) of Diversified Healthcare Trust, a Maryland real estate investment trust (the “Company,” “we,” “us” or “our”), is furnishing this proxy statement and accompanying proxy card (or voting instruction form) to you in connection with the solicitation of proxies by our Board for our 2024 annual meeting of shareholders. To provide all of our shareholders an opportunity to participate in our annual meeting, our annual meeting will be held virtually via live webcast on Friday, May 31, 2024, at 9:30 a.m., Eastern time, subject to any postponements or adjournments (the “2024 Annual Meeting”). We are first making these proxy materials available to shareholders on or about March 26, 2024.
Only owners of record of our common shares of beneficial interest (“Common Shares”) as of the close of business on March 22, 2024, the Record Date for our 2024 Annual Meeting, are entitled to notice of, and to vote at, the meeting and at any postponements or adjournments of the meeting. Holders of Common Shares are entitled to one vote for each Common Share held as of the close of business on the Record Date. Our Common Shares are listed on The Nasdaq Stock Market LLC (“Nasdaq”). At the close of business on March 22, 2024, there were approximately 240,418,363 Common Shares issued and outstanding.
The mailing address of our principal executive office is Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458.
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR OUR
2024 ANNUAL MEETING TO BE HELD ON FRIDAY, MAY 31, 2024.
The Notice of 2024 Annual Meeting, Proxy Statement and Annual Report to Shareholders for the fiscal year ended December 31, 2023 are available at www.proxyvote.com.
 

TABLE OF CONTENTS
PLEASE VOTE
Please vote to participate in our decision making. Nasdaq rules do not allow a broker, bank or other nominee who holds shares on your behalf to vote on nondiscretionary matters without your instructions.
PROPOSALS THAT REQUIRE YOUR VOTE
PROPOSAL
MORE
INFORMATION
BOARD
RECOMMENDATION
VOTES REQUIRED
FOR APPROVAL
1
Election of Trustees
Page 24
   FOR
Plurality of all
votes cast*
2
Advisory vote to approve executive compensation**
Page 41
   FOR
Majority of all
votes cast
3
Ratification of independent auditors**
Page 54
   FOR
Majority of all
votes cast
*
Our Board has adopted a resignation policy pursuant to which an incumbent Trustee who fails to receive a majority of votes cast in an uncontested election will offer to resign from our Board and, in such circumstance, our Board will decide whether to accept or reject the resignation offer.
**
Non-binding advisory vote.
You can vote in advance in one of three ways:
via the internet
[MISSING IMAGE: ic_internet-bw.jpg]
Visit www.proxyvote.com and enter your 16 digit control number provided in your Notice Regarding the Availability of Proxy Materials, proxy card or voting instruction form before 11:59 p.m., Eastern time, on May 30, 2024 to authorize a proxy VIA THE INTERNET.
by phone
[MISSING IMAGE: ic_telephone-bw.jpg]
Call 1-800-690-6903 if you are a shareholder of record and 1-800-454-8683 if you are a beneficial owner before 11:59 p.m., Eastern time, on May 30, 2024 to authorize a proxy BY TELEPHONE. You will need the 16 digit control number provided on your Notice Regarding the Availability of Proxy Materials, proxy card or voting instruction form.
by mail
[MISSING IMAGE: ic_mail-bw.jpg]
Sign, date and return your proxy card if you are a shareholder of record or voting instruction form if you are a beneficial owner to authorize a proxy BY MAIL.
If the meeting is postponed or adjourned, these times will be extended to 11:59 p.m., Eastern time, on the day before the reconvened meeting.
PLEASE VISIT: www.proxyvote.com

To review and download easy to read versions of our Proxy Statement and Annual Report.

To sign up for future electronic delivery to reduce the impact on the environment.

To register in advance to attend our 2024 Annual Meeting.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
1

TABLE OF CONTENTS
PROXY SUMMARY
This proxy summary highlights information which may be provided elsewhere in this Proxy Statement. This summary does not contain all of the information that you should consider, and you should read the entire Proxy Statement carefully before voting. Page references are supplied to help you find further information in this Proxy Statement.
ELIGIBILITY TO VOTE
You can vote if you were a shareholder of record at the close of business on March 22, 2024, the Record Date for our 2024 Annual Meeting.
HOW TO CAST YOUR VOTE (Page 1)
You can vote by any of the following methods:

By Telephone or Internet. All shareholders of record can authorize a proxy to vote their shares by touchtone telephone by calling 1-800-690-6903, or through the internet at www.proxyvote.com, using the procedures and instructions described in your Notice Regarding the Availability of Proxy Materials or proxy card.

By Written Proxy. All shareholders of record also can submit voting instructions by written proxy card. If you are a shareholder of record and receive a Notice Regarding the Availability of Proxy Materials, you may request a written proxy card by following the instructions included in the notice.

Electronically at our 2024 Annual Meeting. All shareholders of record may vote electronically at the meeting. Beneficial owners may vote electronically at our 2024 Annual Meeting if they have a legal proxy.
CORPORATE GOVERNANCE PRINCIPLES (Page 4)
We endeavor to observe and implement best practices in our corporate governance.
SUSTAINABILITY (Page 6)
We have a long-standing commitment to our shareholders and other stakeholders to conduct our business in an environmentally and socially responsible manner.
VOTING (Page 1, 24, 41 & 54)
PROPOSAL
BOARD RECOMMENDATION
VOTES REQUIRED
FOR APPROVAL
 1
Election of Trustees
   FOR
Plurality of all
votes cast*
 2
Advisory vote to approve executive compensation**
   FOR
Majority of all
votes cast
 3
Ratification of independent auditors**
   FOR
Majority of all
votes cast
*
Our Board has adopted a resignation policy pursuant to which an incumbent Trustee who fails to receive a majority of votes cast in an uncontested election will offer to resign from our Board and, in such circumstance, our Board will decide whether to accept or reject the resignation offer.
**
Non-binding advisory vote.
With respect to Proposal 1, you may vote “FOR” or “WITHHOLD” with respect to each nominee. You may vote “FOR,” “AGAINST” or “ABSTAIN” on Proposals 2 and 3.
 
2
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
PROPOSAL 1: ELECTION OF TRUSTEES (Page 24)
Upon the recommendation of our Nominating and Governance Committee, our Board has nominated John L. Harrington, Lisa Harris Jones, Phyllis M. Hollis, Dawn K. Neher and Jeffrey P. Somers as Independent Trustees and Christopher J. Bilotto and Adam D. Portnoy as Managing Trustees. Presented below is the expected composition of our Board immediately following our 2024 Annual Meeting, assuming the election of our Trustee nominees and the expiration of Jennifer F. Francis’s term as a Trustee.
NAME OF TRUSTEES
INDEPENDENT
COMMITTEE MEMBERSHIP
Christopher J. Bilotto None
John L. Harrington
Audit (Chair)
Lisa Harris Jones
Audit
Compensation
Nominating and Governance
Phyllis M. Hollis
Audit
Compensation (Chair)
Dawn K. Neher
None(1)
Adam D. Portnoy None
Jeffrey P. Somers
Audit
Compensation
Nominating and Governance (Chair)
(1)
Ms. Neher may be appointed to one or more of the Board’s committees following our 2024 Annual Meeting, assuming her election as an Independent Trustee.
PROPOSAL 2: ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION (Page 41)
COMPENSATION DISCUSSION AND ANALYSIS (Page 42)
Our compensation structure is unique because of our relationship with our manager, The RMR Group LLC (“RMR”). Our business management agreement with RMR is designed to incentivize RMR to provide the highest quality services to us. Our Compensation Committee believes that our executive compensation program is appropriately designed to incentivize strong performance over the long term.
PROPOSAL 3: RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS INDEPENDENT AUDITORS (Page 54)
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
3

TABLE OF CONTENTS
CORPORATE GOVERNANCE PRINCIPLES AND BOARD MATTERS
Review of Corporate Governance Policies and Shareholder Engagement
   
Our Board is committed to upholding the values of good corporate governance. In recognition of the relationship between corporate governance and long term performance, and as a result of our ongoing engagement with our shareholders, our Board continues to proactively evaluate our corporate governance principles. Based on these principles, our Board has:

since 2020, nominated four new Independent Trustees to our Board as part of our Board refreshment plan and increased the size of our Board to seven members and the percentage of our Board comprised of Independent Trustees to 71%, assuming the election of our Trustee nominees;

amended our Declaration of Trust to declassify our Board so that all of our Trustees stand for election annually, a measure which was supported by more than 71% of our shareholders;

conducted an annual shareholder outreach and engaged with shareholders who hold approximately 65% of our Common Shares;

adopted new Environmental, Social and Governance (“ESG”) policies in connection with our efforts to lead a sustainable business and continue to improve our internal culture and the communities in which we operate;

retained Korn Ferry, a leading executive search and consulting firm, to identify and vet candidates to expand and refresh our Board; and

enhanced our compensation and sustainability disclosure and reporting in response to shareholder feedback.
We appreciate your support on these initiatives.
Board Composition, Expansion and Refreshment
   
Ensuring our Board is comprised of Trustees who bring diverse viewpoints and perspectives, have a variety of skills, professional experience and backgrounds and effectively represent the long term interests of our shareholders is a top priority of our Board and our Nominating and Governance Committee. Our Board regularly evaluates its composition. Our Board’s expansion and refreshment activities have increased the ratio of Independent Trustees to Managing Trustees, created more skill mix and diversity and ensured a smooth transition as Trustees retire from our Board. We are currently governed by a six member Board of Trustees, including four Independent Trustees and two Managing Trustees. Assuming the election of our Trustee nominees at our 2024 Annual Meeting, we will be governed by a seven member Board of Trustees, including five Independent Trustees and two Managing Trustees. Our Nominating and Governance Committee and our Board have an ongoing engagement with Korn Ferry, a leading executive search and consulting firm, to act as an advisor and to assist our Nominating and Governance Committee in:

identifying and evaluating potential trustee candidates;

creating an even playing field among candidates identified regardless of source;

using the criteria, evaluations and references to prioritize candidates for consideration regardless of source; and

assisting in attracting and vetting candidates.
Process for Selecting Trustees
   
Our Nominating and Governance Committee screens and recommends candidates for nomination by our full Board. Our Nominating and Governance Committee is assisted with its recruitment efforts by its ongoing engagement with Korn Ferry, which recommends candidates that satisfy our Board’s criteria. They also provide research and pertinent information regarding candidates, as requested.
 
4
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
[MISSING IMAGE: fc_process-4c.jpg]
ISG Corporate Governance Framework
   
We follow the Investor Stewardship Group’s (“ISG”) Corporate Governance Framework for U.S. Listed Companies, as summarized below:
ISG Principle
Our Practice
Principle 1:
Boards are accountable to shareholders.

All of our Trustees stand for annual election.

We adopted a proxy access bylaw.

We have a resignation policy pursuant to which an incumbent Trustee who fails to receive a majority of votes cast in an uncontested election will offer to resign from our Board and, in such circumstance, our Board will decide whether to accept or reject the resignation offer.
Principle 2:
Shareholders should be entitled to voting rights in proportion to their economic interest.

We do not have a dual class structure; each shareholder gets one vote per share.
Principle 3:
Boards should be responsive to shareholders and be proactive in order to understand their perspectives.

In 2023, we had a proactive shareholder outreach and had active engagements with shareholders owning approximately 65% of our Common Shares.

Our engagement topics included business strategies, governance reform priorities, sustainability and social strategy, Board composition, leadership and refreshment, succession planning and executive compensation program disclosure.
Principle 4:
Boards should have a strong, independent leadership structure.

We have a Lead Independent Trustee with clearly defined duties and robust responsibilities that are disclosed to shareholders.

Our Board considers the appropriateness of its leadership structure at least annually.

All of our committees are comprised solely of Independent Trustees.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
5

TABLE OF CONTENTS
ISG Principle
Our Practice
Principle 5:
Boards should adopt structures and practices that enhance their effectiveness.

71% of Board members are independent, assuming the election of our Trustee nominees.

Our Board includes members of underrepresented communities and, assuming the election of our Trustee nominees, our Board will be comprised of 43% women and 29% African American persons.

We have an active Board refreshment plan, including an ongoing engagement with an executive search and consulting firm to identify and evaluate candidates to expand and refresh our Board; four new independent Board members have joined our Board in the last four years if Dawn K. Neher is elected as an Independent Trustee by our shareholders at our 2024 Annual Meeting.

Our Trustees then in office attended at least 75% of all Board and applicable committee meetings in 2023, and each of our Trustees then in office attended the 2023 annual meeting of shareholders.
Principle 6:
Boards should develop management incentive structures that are aligned with the long term strategy of the company.

Our Compensation Committee annually reviews and approves incentive compensation program design, goals and objectives for alignment with compensation and business strategies.

Although we do not pay any cash compensation directly to our officers and have no employees, we have adopted the Amended and Restated 2012 Equity Compensation Plan (the “Share Award Plan”) to reward our named executive officers and other employees of RMR who provide services to us and to align their interests with those of our shareholders.

RMR’s compensation is tied to our performance.
Shareholder Engagement and Outreach
   
We conduct shareholder outreach throughout the year to engage with shareholders on issues important to them. Our Board receives reports on this engagement as well as any specific issues to be addressed.
[MISSING IMAGE: fc_outreach-4c.jpg]
Sustainability
   
Overview. Our business strategy for our life science and medical office portfolio (our “Office Portfolio”) incorporates a focus on sustainable approaches to operating these properties in a manner that benefits our shareholders, tenants and the communities in which we are located. We seek to operate those properties in ways that improve the economic performance of their operations, while simultaneously ensuring tenant comfort and safety and managing energy and water consumption, as well as greenhouse gas emissions.
Our strategy for our senior housing operating portfolio (“SHOP”) is to work with our SHOP managers, to prioritize the safety and well-being of our residents, while also seeking to maximize the operating efficiencies of our senior living communities.
 
6
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
Our environmental, social and governance initiatives for our Office Portfolio are primarily implemented by our manager, RMR, and for our SHOP, by our operators, including Five Star Senior Living (“Five Star”), an operating division of AlerisLife Inc. (“AlerisLife”), and focus on a complementary set of objectives, including the following:

Responsible Investment: We seek to invest capital in our properties that both improves environmental performance and enhances asset value. During the acquisition of properties, RMR assesses, among other things, environmental sustainability opportunities and physical and policy driven climate related risks as part of the due diligence process.

Environmental Stewardship: We seek to improve the environmental footprint of our properties, including by reducing greenhouse gas emissions, energy consumption and water usage, especially when doing so may reduce operating costs and enhance the properties’ competitive position. As a result of these ongoing efforts RMR has helped in generating the following portfolio-wide achievements for our Office Portfolio:

Certifying more than 2.2 million square feet across 23 properties through the Environmental Protection Agency’s (“EPA”) ENERGY STAR® program, representing 28.1% of ENERGY STAR certification-eligible square feet;

Benchmarking 3.6 million square feet across 53 properties, using the EPA’s ENERGY STAR® Portfolio Manager tool;

Certifying 2.2 million square feet of our properties as Leadership in Energy and Environmental Design (“LEED”) certified properties, a certification program by the U.S. Green Building Council that recognizes performance in location and planning, sustainable site development, water savings, energy efficiency, materials selection, waste reduction, indoor environmental quality, innovative strategies and attention to priority regional issues. 1.4 million square feet are certified to a LEED Gold level; and

Earning recognition as a Gold-Level 2023 Green Lease Leader by the U.S. Department of Energy’s Better Buildings Alliance and the Institute for Market Transformation for leasing activities that include lease clauses that promote energy efficiency and increased collaboration between tenant and landlord aiming to reduce the carbon footprint and operating costs of our properties.
In 2022, RMR announced its “Zero Emissions Promise.” For all properties for which RMR directly manages energy, which includes 102 properties in our Office Portfolio, RMR is committing to a goal of net zero by 2050 and a 50% reduction by 2029 from a 2019 baseline as it relates to scope 1 and 2 emissions. RMR’s 50% reduction commitments have been validated by the Science-based Targets Initiative. We believe that our properties that fall within RMR’s operational carbon neutrality commitments will benefit from these emissions reduction efforts and that achieving net zero emissions will occur through a combination of strategic capital investments in energy efficiency, stakeholder engagement to promote sustainable behavior, deployment of on-site solar and the purchase of energy from renewable sources.

Quality of the Resident Experience in our SHOP properties: Our operators provide comprehensive resident enrichment programs and memory care programming designed to provide our residents fulfilling lives and positive experiences at our communities.

Certifying more than 1.1 million square feet of SHOP properties through the EPA ENERGY STAR® program.

Investments in Human Capital: We have no employees of our own. We rely on our manager, RMR, to hire, train, and develop a workforce that meets the needs of our business, contributes positively to our society and helps reduce our impact on the natural environment.
RMR
RMR employs approximately 1,100 real estate professionals across the United States. In 2023, RMR was recognized by The Boston Globe for the fourth consecutive year as one of The Top Places to Work in Massachusetts in the Large Employers category and by the EPA as an “ENERGY STAR Partner of the Year, Sustained Excellence.” In 2021, RMR received the Excellence Award from the Institute of Real Estate Management. In 2020, RMR was recognized by the Boston Business
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
7

TABLE OF CONTENTS
Journal as the “Fastest Growing Middle Market Company in Massachusetts,” and by Commercial Property Executive as 9th in its list of Top Commercial Property Management Companies.
RMR’s recruiting programs, on-boarding, retention programs and its development and training programs currently include the following:

LiveWell Employee Wellness Program: RMR’s LiveWell program was launched in 2016 with the goal of providing resources and incentives to enhance employees’ physical, emotional and financial wellness. LiveWell includes a range of educational presentations, webinar series and wellness competitions.

Managing with Impact: Since 2016, RMR hosted Managing with Impact workshops for managers throughout the company to expand their perspectives and increase their confidence as a new manager. Within their first year, managers complete the workshop and learn how to effectively delegate, solve problems and give meaningful performance feedback.

Tuition Reimbursement Program: RMR offers tuition assistance up to $20,000 annually for work-related education from accredited colleges and universities in order to deepen employees’ skillsets and support personal enrichment.

Accelerated Women in Leadership Program: RMR’s Accelerated Women in Leadership Program (“AWLP”) is a targeted learning experience that helps women strengthen and leverage their contribution and impact as professionals and leaders. Participants explore a variety of topics that help them manage biases that can be limiting, strengthen their executive presence, influence and negotiate more effectively, and integrate work and home life. Starting in 2020, a cohort of women professionals participate in AWLP each year.

Analyst Accelerator Internship Program: RMR’s Analyst Accelerator Internship Program is designed to attract early career talent to our industry from backgrounds underrepresented in real estate. The 10-week program is built upon the premise that hands on exposure as an analyst is an ideal way to provide rising college juniors or seniors with a solid first step toward a successful and lasting career in real estate. RMR actively recruits talent from college campuses and student communities interested in real estate who are traditionally underrepresented in the sector, including women and people of color. Relationships with programs like the University of Massachusetts Amherst Real Estate Program, involvement with Historically Black Colleges and Universities, and engagement with women’s career forums all amplify RMR’s outreach efforts to develop a robust and diverse talent pipeline.

Next Generation Executive Program: From 2021 through 2023, RMR sponsored eight rising leaders in The Partnership, Inc.’s Next Generation Executive Program (“NGE”). Admission to NGE is highly competitive and limited to a select group of America’s most promising multicultural leaders. The program prepares future leaders to meet the unique challenges facing today’s senior executive. Program areas include strategic innovation, organizational change, operating in a global market, team leadership and executive resiliency.
RMR also prioritizes on-going education and training for all employees across their organization as follows:

Engineering Apprenticeship Program: Given the increasing challenges within the real estate industry of attracting a qualified and diverse pool of engineers throughout the country, RMR made it a strategic focus to develop the next generation of qualified building engineers. RMR’s Engineering Apprenticeship Program standardizes the recruitment and development of engineering candidates to prepare them for open positions and to plan for future engineering needs. RMR recruits from various trade schools and job fairs to identify candidates for the two-year program with a curriculum that includes specific onboarding plans for training in electrical, heating, ventilation and air conditioning (“HVAC”), or plumbing trades and covers a range of essential engineering staff development topics.

Industry Associations & Credentials: In order to further their professional development, many of RMR’s employees seek out credentials and association memberships, with any membership costs reimbursed by RMR. Examples of credentials and association memberships include: Building Owners and Managers Association Membership and Event Participation, Certified Property Manager, Certified Public Accountant, National Association
 
8
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
of Industrial and Office Properties, LEED Accredited Professional, Certified Energy Manager and Fitwel Ambassador.

Corporate Citizenship: We seek to be a responsible corporate citizen and to strengthen the communities in which we own properties through our policies and charitable giving. RMR regularly encourages its employees to engage in a variety of charitable and community programs, including participation in a RMR company-wide service day and a charitable giving matching program.

Diversity & Inclusion: We value a diversity of backgrounds, experience and perspectives. Assuming the election of our Trustee nominees at our 2024 Annual Meeting, our Board will be comprised of 43% women and 29% African American persons. We have no employees of our own but our manager, RMR, is an equal opportunity employer with all qualified applicants receiving consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status. RMR is committed to racial equality and fostering a culture of diversity and inclusion. As of December 31, 2023, 41% and 32% of RMR’s employees were female and non-white, respectively.
RMR has made diversity and inclusion an important part of its hiring, retention and development programs. RMR has enhanced its hiring policies to support increasing diversity within its workforce. For every open position not filled by internal candidates, hiring managers are required to have at least one qualified woman or member of underrepresented community candidate in the final round interviews before an offer is extended to fill the position. A RMR manager who is a woman and/or member of an underrepresented community is required to be part of the final round interview team. In addition, RMR works with strategic industry partners like Commercial Real Estate Women (“CREW”) and The Partnership, Inc. for posting new positions and supporting multicultural professionals.
[MISSING IMAGE: pc_rmr-pn.jpg]
(1)
RMR uses EEO Ethnicity and Race Categories to estimate the diversity of its workforce. EEO Ethnicity and Race Categories include Asian, Black or African American, Hispanic or Latino, American Indian or Alaskan Native, Native Hawaiian or other Pacific Islander, or multiracial background.
To Learn more about RMR’s and our sustainability initiatives, visit www.rmrgroup.com/corporate-sustainability.
SHOP Managers
All SHOP managers strive to provide a high quality workplace experience and competitive total rewards program for their team members. AlerisLife manages the majority of our communities. An overview of AlerisLife’s employee programs is included below.
AlerisLife
As of December 31, 2023, AlerisLife had approximately 10,900 team members in which approximately 77% and 57% of were female and non-white, respectively. AlerisLife’s team member engagement initiatives align with its goal of being an employer of choice with a thriving workforce that encourages career enrichment and positions it for growth. AlerisLife’s recruiting programs, on-boarding and retention programs and development and ongoing training programs currently include the following:
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
9

TABLE OF CONTENTS

Team Member Total Rewards: AlerisLife provides team members a competitive total rewards program that includes competitive salaries and a broad range of sponsored benefits such as a 401(k) plan, healthcare and insurance benefits, health savings and flexible spending accounts, paid time off and tuition assistance. In February 2024, AlerisLife launched the “Nourish You” campaign, providing all team members a balanced nutritious meal during their work shift.

Team Member Engagement: Management reviews team member engagement and satisfaction surveys to monitor employee morale and receive feedback on a variety of issues. In the year ended December 31, 2022, AlerisLife had its highest ever engagement survey participation, with an increase in favorable responses. In the year ended December 31, 2023, AlerisLife engagement survey participation continued to show improvement towards its goal of being “great place to work” certified.

Rewards: AlerisLife rewards team members for innovation and productivity. It has several recognition programs for team members at various levels of the organization. AlerisLife also enhanced its recognition programs and incentives linked to its corporate values, years of service and achievement of company occupancy objectives.

Tuition Reimbursement Program: AlerisLife offers tuition assistance for work-related education from accredited colleges and universities in order to deepen team members’ skill sets and support personal enrichment.
AlerisLife also prioritizes ongoing education and training for all team members across the organization as follows:

Training and Development: AlerisLife offers a robust learning management platform to provide training and development opportunities to all team members. In 2023, AlerisLife launched and delivered the “High Impact Conversation” training program to all individuals that directly manage others. In addition, it orchestrated its first ever field leadership conference designed to reinforce the training programs on specific skills attributable to sales, marketing, finance and operational excellence.

Industry Associations & Credentials: In order to further their professional development, many of AlerisLife’s team members seek out credentials or hold professional licenses and association memberships. Examples of credentials, professional licenses and association memberships include: Medical License, Licensed Practical Nurse, Registered Nurse, Certified Medical Assistants, Certified Physical and Occupational Therapists, Speech-Language Pathologist, Certified Fitness Trainers, Cardiopulmonary resuscitation certifications (“CPR”), First Aid Certification, Law License and Certified Public Accountant accreditations.
Sustainability Accounting Metrics. The following disclosures are informed by the guidance of the Sustainability Accounting Standards Board (“SASB”) Industry Standard for Real Estate Version 2023-06. To the extent an accounting metric, as defined by the SASB Standard, is not applicable to our portfolio or data to report on the applicable accounting metric is not available to us, we have not made any disclosure.
For the following disclosures, our properties are reported in two segments, our Office Portfolio and our SHOP and is consistent with how these properties and our operating results are presented in our other SEC filings. The information presented is as of December 31, 2023, unless otherwise noted. Additionally, for all sustainability accounting metrics, Same Property includes properties owned continuously since January 1, 2022 and excludes properties classified as held for sale, closed or out of service undergoing redevelopment, if any, thirty-six non-segment properties and two unconsolidated joint ventures that own medical office and life science properties with an aggregate of approximately 204,688 rentable square meters in which DHC owns an equity interest.
I.
Energy management integration discussion (SASB Accounting Metric Code: IF-RE-130a.5).
RMR deploys on our behalf energy management best practices at our Office Portfolio, which include:

Centralized utility bill processing and payment system;

ENERGY STAR® benchmarking and certifications;

Real-time energy monitoring;
 
10
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS

Daytime and nighttime energy audits;

Light Emitting Diodes lighting upgrades;

Annual energy engagement competitions;

Energy performance training for property operations teams;

Utilize green lease language, where possible, to promote mutual commitment to environmentally friendly practices and operational efficiencies with our tenants;

Energy performance review for end-of-life HVAC equipment replacements; and

Capital deployment dedicated to generating returns on energy efficiency upgrades.
As a result of these energy management efforts, we have reduced energy and water usage helping to generate both economic and environmental benefits.
Some cities and states in which we own properties require annual whole-building energy and water use disclosure or achieving certain energy or emissions performance standards. In these jurisdictions, RMR engages with tenants to collect and report any direct tenant-paid energy and water consumption. RMR’s programs also aid in complying with building performance standards by actively seeking out cost effective ways to reduce energy and emissions across properties managed by them and where tenants directly manage energy.
Sections II, III and IV below provide SASB-aligned energy-related metrics.
II.
Energy consumption data coverage as a percentage of total floor area, by property sector (SASB Accounting Metric Code: IF-RE-130a.1).
The following illustrates energy data available as compared to the total population of our properties, by sector.
[MISSING IMAGE: bc_coverage-pn.jpg]
A majority of the properties not included in the percentage of square feet covered are properties where tenant manages energy utility accounts directly and data is not currently shared with us.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
11

TABLE OF CONTENTS
III.
Total energy consumed in gigajoules (“GJ”) by portfolio area with data coverage, percentage grid electricity and percentage renewable, by sector (SASB Accounting Metric Codes: IF-RE-130a.2).
[MISSING IMAGE: bc_energy-pn.jpg]
None, or 0%, of the renewable energy consumed was directly purchased through power purchase agreements or by other explicit contractual means.
IV.
Same Property percentage change in energy consumption for the portfolio area with data coverage, by sector (SASB Accounting Metric Code: IF-RE-130a.3).
[MISSING IMAGE: bc_property-pn.jpg]
 
12
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
V.
Percentage of eligible portfolio that (i) has obtained an energy rating and (ii) is certified to ENERGY STAR®, by sector (SASB Accounting Metric Code: IF-RE-130a.4).
[MISSING IMAGE: bc_rating-pn.jpg]
See SASB Accounting Metric Code 130a.5 in Section I for a description of how building energy management considerations are integrated into property investment analysis and operational strategy.
VI.
Water management integration discussion (SASB Accounting Metric Code: IF-RE-140a.4).
On our behalf, RMR supports water management practices at our Office Portfolio that reduce operating costs as well as our impact on the consumption of natural resources. Water usage is managed by benchmarking water performance to establish a baseline and to measure performance improvements resulting from conservation measures. Water benchmarking is performed through the EPA’s ENERGY STAR® Portfolio Manager online platform.
Some cities and states in which we own properties require annual whole-building energy and water use disclosure. In these jurisdictions, RMR engages with tenants to collect and report any direct tenant-paid energy and water consumption for our Office Portfolio.
RMR also routinely implements water efficiency and water use reduction projects for our Office Portfolio, which include upgrades to indoor plumbing fixtures, low-flow water closets and urinals, low-flow flush valves, low-flow automatic faucet controls, low-flow faucet aerators and shower heads, water-efficient landscaping, cooling tower water management and leak detection and notification.
Sections VII, VIII and IX below provide SASB-aligned water-related metrics.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
13

TABLE OF CONTENTS
VII.
Water withdrawal data coverage in square feet and as a percentage of total floor area and percentage in regions with High or Extremely High Baseline Water Stress (“BWS”), by sector (SASB Accounting Metric Codes: IF-RE-140a.1).
[MISSING IMAGE: bc_water-pn.jpg]
Baseline Water Stress measures total annual water withdrawals (municipal, industrial, and agricultural) expressed as a percent of the total annual available flow. Higher values indicate more users are competing for limited water supplies.
VIII.
Total water withdrawn by portfolio area with data coverage and percentage in regions with High or Extremely High Baseline Water Stress, by sector (SASB Accounting Metric Code: IF-RE-140a.2).
[MISSING IMAGE: bc_withdraw-pn.jpg]
 
14
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
IX.
Same Property percentage change in water withdrawn for portfolio area with data coverage, by sector (SASB Accounting Metric Code: 140a.3).
[MISSING IMAGE: bc_percent-pn.jpg]
X.
Percentage of new leases that contain a cost recovery clause for resource efficiency-related capital improvements and associated leased floor area (SASB Accounting Metric Code: IF RE-410a.1).
92.5%, or 39,707 square meters, of Office Portfolio leases executed in 2023 included a cost recovery clause for resource efficiency-related capital improvements.
XI.
Description of approach to measuring, incentivizing, and improving sustainability impacts of tenants (SASB Accounting Metric Code: IF-RE-410a.3).
On our behalf, RMR seeks to provide best-in-class Office Portfolio operations and healthy, efficient environments for our tenants and encourage continual engagement that promotes long-lasting relationships and sustainable behaviors.
RMR has internal policies that govern environmentally responsible property operations. We also utilize green lease language, where possible, to promote mutual commitment to environmentally friendly practices and operational efficiencies with our tenants. These efforts earned us Green Lease Leader Gold recognition in 2021 through 2023.
RMR prioritizes LEED certification and recertification projects by reviewing a variety of sustainability and leasing criteria such as high ENERGY STAR® scores and access to public transportation and near-by amenities. We believe that taking the initiative to submit for and attain LEED certification adds value to our properties and enhances tenant satisfaction, which reflects our commitment to environmental sustainability.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
15

TABLE OF CONTENTS
XII.
Area of properties located in FEMA Special Flood Hazard Areas or foreign equivalent, by sector (SASB Accounting Metric Code: IF-RE-450a.1).
[MISSING IMAGE: bc_hazard-pn.jpg]
XIII.
Description of climate change risk exposure analysis, degree of systematic portfolio exposure, and strategies for mitigating risks (SASB Accounting Metric Code: IF-RE-450a.2).
We define climate change resilience as our ability to anticipate, prepare for and recover from adverse physical climate activity such as increased severity of acute weather events and chronic changes to weather patterns as well as identify and plan for climate-related transitional activities such as changes in policy and market-driven expectations.
In preparation for and in response to property-level natural hazards, RMR utilizes dynamic geographic mapping tools which allows them to quickly assess the risk to our Office Portfolio from the rapidly changing natural hazards related to coastal and river flooding and other potential adverse impacts that may occur from named storms.
In advance of a natural hazard event, RMR directs resources to our Office Portfolio identified as potentially impacted through these mapping tools. The resources made available include access to senior management and mobilization of equipment and personnel. Rapid response personnel may also be directed to properties after a weather event has occurred.
Properties susceptible to inundation from flood waters are evaluated routinely. The evaluation may include implementing tenant and local agency coordination protocols, property incident response plan reviews, insurance provider assessments and the implementation of physical protection elements, such as flood and wind protection barriers.
We routinely utilize technology to evaluate our properties for energy and water performance. Such activities support lower operating expenses, improve comfort for our tenants and reduce our exposure to impacts from policies targeting building energy performance and greenhouse gas emissions.
Our portfolio strategy includes the development of hazard and vulnerability assessments of our existing properties and scenario planning and economic risk reviews of property development opportunities over long-term ownership periods. In 2021 RMR, in coordination with a third-party consultant, began physical climate scenario analyses for substantially all our properties. The climate scenario assessments under evaluation include current physical climate risk exposure and assessments of future physical climate risk exposure models that consider a “business as usual” approach, a 2.0°C emissions mitigation approach in line with the Paris Climate Agreement and a
 
16
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
“middle” approach, all based on the Intergovernmental Panel on Climate Change sixth assessment Representative Concentration Pathways 8.5, 2.6, and 4.5, respectively. The following table summarizes physical and transitional climate change risks and opportunities identified for our portfolio.
Risks
Opportunities

Over time, chronic or acute climate stressors such as extreme heat, increased precipitation, inland flooding or storm surges could lead to the need for capital investments to meet landlord commitments or improve asset resilience.

Increases in regional water stress may lead to water use restrictions and impact our operators’ and tenants’ ability to provide services to their guests and patrons.

Energy or emissions performance standards require capital investments to meet standards and offset regulatory fines.

Maintaining comfort for vulnerable populations may become more costly for SHOP managers.

Maintaining electrical power during climate disasters is critical.

Energy-efficient, low-carbon footprint and climate change resilient properties may be in high demand, increasing revenue potential.

On-site solar power generation can drive down utility expenses and provide clean energy and covered parking for tenants. Battery energy storage may further reduce operating expenses and contribute to an increase of localized grid reliability.

Innovative solutions such as smart buildings, healthy buildings and buildings with sought-after amenities such as and electric vehicle (EV) charging stations may attract high-quality, investment-grade tenants.

Senior living communities provide safe environments during climate-related emergencies.
XIV.
SASB Activity Metrics.
Code
Activity Metric
Value
IF-RE-000.A Number of assets
Office Portfolio: 102
SHOP: 232
IF-RE-000.B Leasable floor area (square meters)
Office Portfolio: 799,888
SHOP: 2,312,301
IF-RE-000.C
Percentage of indirectly managed assets
Office Portfolio: 39.6%
SHOP: 100%
IF-RE-000.D Average occupancy rate
Office Portfolio: 85.7%
SHOP: 78.1%
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
17

TABLE OF CONTENTS
Key Responsibilities of Our Board
   
Oversight of Strategy
Oversight of Risk
Succession Planning

Our Board oversees and monitors strategic planning.

Business strategy is a key focus of our Board and embedded in the work of Board committees.

Company management is charged with executing our business strategy and provides regular performance updates to our Board.

Our Board oversees risk management.

Board committees, which meet regularly and report back to our full Board, play significant roles in carrying out the risk oversight function.

Company management is charged with managing risk, through robust internal processes and effective internal controls.

Our Board oversees succession planning and talent development for senior executive positions.

Our Nominating and Governance Committee makes an annual report to our Board on succession planning.

In the event of a succession, our entire Board may work with our Nominating and Governance Committee, or the Independent Trustees, as applicable, to nominate and evaluate potential successors.
Our Board’s Role in Oversight of Risk Management
   
Our Board is elected by our shareholders to, among other things, oversee our business and long term strategy. As part of fulfilling its responsibilities, our Board oversees the maintenance of appropriate financial and other internal controls and our compliance with applicable laws and regulations. Inherent in these responsibilities is our Board’s understanding and oversight of the various risks we face. Our Board considers that risks should not be viewed in isolation and should be considered in virtually every business decision and as part of our business strategy.
Our Board oversees risk as part of its general oversight of our Company. Oversight of risk is addressed as part of various Board and Board committee activities and through regular and special Board and Board committee meetings. Our day to day business is conducted by our manager, RMR, and RMR and our officers are responsible for incorporating risk management in their activities. Our management and members of our internal audit group regularly meet with our Audit Committee and provide us with advice and assistance with our risk management function.
In discharging their oversight responsibilities, our Board and Board committees regularly review a wide range of reports provided by RMR and other service providers, including:

reports on market and industry conditions;

operating and regulatory compliance reports;

financial reports;

reports on risk management and our ESG activities and initiatives;

regulatory and legislative updates that may impact us;

reports on the security of our information technology processes and our data; and

legal proceeding updates and reports on other business related matters.
Our Board and Board committees discuss these matters among themselves and with representatives of RMR, our officers, members of our internal audit group, legal counsel, our independent auditors and other professionals, as appropriate.
 
18
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
Our Audit Committee takes a leading role in helping our Board fulfill its responsibilities for oversight of our financial reporting, internal audit function, risk management, including cybersecurity, and our compliance with legal and regulatory requirements. Our Board and Audit Committee review reports annually from our independent auditors regarding potential risks, including risks related to our internal control over financial reporting, and at other times, as may be warranted. Our Audit Committee also annually reviews an internal audit plan developed by members of our internal audit group with the goal of helping us systematically evaluate the effectiveness of our risk management, control and governance processes on an annual basis. Our Audit Committee meets at least quarterly and reports its findings and results of its monitoring activities and oversight on our financial reporting, internal audit function, risk management, including cybersecurity, and our compliance with legal and regulatory requirements, as applicable, to our Board. Our Audit Committee also meets quarterly with members of our internal audit group to review the results of our internal audits and receive reports, and directs or recommends to our Board actions or changes it determines appropriate to enhance or improve the effectiveness of our risk management, including cybersecurity, as it determines appropriate.
Our Audit Committee considers risks related to cybersecurity, and receives annual reports from our management regarding cybersecurity risks and countermeasures being undertaken or considered by us, including updates on the internal and external cybersecurity landscape and relevant technical developments, and more frequent reports as it may direct or as warranted. RMR has conducted an external assessment of its cybersecurity controls using a qualified third party. In addition, RMR’s cybersecurity program is aligned to the National Institute of Standards and Technology Cybersecurity Framework. RMR conducts annual data security education and testing for its employees, including RMR employees who provide services to us, in addition to penetration testing and unannounced email phishing exercises.
Our Compensation Committee whose responsibilities are detailed in its charter, among other responsibilities, evaluates RMR’s performance under our business and property management agreements, including any perceived risks created by compensation arrangements. Also, our Compensation Committee and our Board consider that we have a share award program that requires share awards to executive officers to vest over a period of years. We believe that the use of share awards vesting over time rather than stock options mitigates the incentives for our management to undertake undue risks and encourages management to make long term and appropriately risk balanced decisions.
It is not possible to identify all of the risks that may affect us or to develop processes and controls to eliminate all risks and their possible effects, and processes and controls employed to address risks may be limited in their effectiveness. Moreover, it is necessary for us to bear certain risks to achieve our objectives. As a result of the foregoing and other factors, our ability to manage risk is subject to substantial limitations.
To learn more about the risks we face, you can review the matters discussed in Part I, Item 1A. “Risk Factors” and “Warning Concerning Forward-Looking Statements” in our Annual Report to Shareholders for the fiscal year ended December 31, 2023 (the “Annual Report”). The risks described in the Annual Report are not the only risks we face. Additional risks and uncertainties not currently known or that may currently be deemed to be immaterial also may materially adversely affect our business, financial condition or results of operations in future periods.
Trustee Independence
   
Under the corporate governance listing standards of the Nasdaq and our governing documents, our Board must consist of a majority of Independent Trustees. Under our governing documents, Independent Trustees are Trustees who are not employees of RMR, are not involved in our day to day activities and who meet the qualifications for independence under the applicable rules of the Nasdaq and the SEC.
Our Board affirmatively determines whether Trustee nominees have a direct or indirect material relationship with us, including our subsidiaries, other than serving as our Trustees or trustees or directors of our subsidiaries. In making independence determinations, our Board observes the Nasdaq and SEC criteria, as well as the criteria set forth in our governing documents. When assessing a Trustee nominee’s relationship with us, our Board considers all relevant facts and circumstances, not merely from the Trustee nominee’s standpoint, but also from that of the persons or organizations with which the Trustee nominee has an affiliation. Based on this review, our Board has determined that John L. Harrington, Lisa Harris Jones, Phyllis M. Hollis,
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
19

TABLE OF CONTENTS
Dawn K. Neher and Jeffrey P. Somers currently qualify as independent trustees under applicable Nasdaq and SEC criteria and as Independent Trustees under our governing documents. In making these independence determinations, our Board reviewed and discussed additional information provided by us and the Trustee nominees with regard to each of the Trustee nominees’ relationships with us, RMR or The RMR Group Inc. (“RMR Inc.”), the managing member of RMR, and the other companies to which RMR provides management services (the “RMR Clients”). Our Board has concluded that none of these five Trustee nominees possessed or currently possesses any relationship that could impair his, her or their judgment in connection with his, her or their duties and responsibilities as a Trustee or that could otherwise be a direct or indirect material relationship under applicable Nasdaq and SEC standards.
Executive Sessions of Independent Trustees
   
Pursuant to our Governance Guidelines, our Independent Trustees are expected to meet at least twice per year in regularly scheduled meetings at which only Independent Trustees are present. Our Independent Trustees also meet with our officers, other representatives of our management, as appropriate, and with our independent auditors. The presiding Trustee for purposes of leading Independent Trustee sessions will be the Lead Independent Trustee, unless the Independent Trustees determine otherwise.
Board Leadership Structure
   
All Trustees play an active role in overseeing our business both at our Board and committee levels. As set forth in our Governance Guidelines, the core responsibility of our Trustees is to exercise sound, informed and independent business judgment in overseeing our Company and our strategic direction. Our Trustees are skilled and experienced leaders and currently serve or have served in government, as members of senior management in public and private for profit and nonprofit organizations and law firms, and have also served in academia. Our Trustees may be called upon to provide solutions to various complex issues and are expected to, and do, ask hard questions of our officers and advisors. Our Board is small, which facilitates informal discussions and communication from management to our Board and among Trustees.
Adam D. Portnoy serves as Chair of our Board. Our Board believes that Mr. Portnoy’s leadership of RMR and extensive familiarity with our day to day business provide valuable insight for our Board.
Four of our Trustees are independent under the applicable Nasdaq and SEC criteria and our governing documents. All of the members of our Audit Committee, Nominating and Governance Committee and Compensation Committee are independent under the applicable listing requirements and rules of the Nasdaq and other applicable laws, rules and regulations, including those of the SEC. As set forth in our governing documents, two of our Trustees are Managing Trustees, persons who have been employees, officers or directors of RMR or RMR Inc., or who have been involved in our day to day activities for at least one year prior to his, her or their election as Trustees.
Lead Independent Trustee
   
We have a Lead Independent Trustee who is selected annually by the vote of a majority of our Independent Trustees. Currently, Ms. Harris Jones serves as our Lead Independent Trustee. Our Lead Independent Trustee has well-defined, robust responsibilities that include:

assisting the Board in evaluating its effectiveness;

presiding at all meetings of our Board at which the Chair or a Managing Trustee is not present;

presiding at all meetings and executive sessions of the Independent Trustees;

having the authority to call meetings of the Independent Trustees or executive sessions of the Independent Trustees;

serving as the principal liaison between the Independent Trustees and our senior management team;

assisting our Compensation Committee in its annual evaluation of the performance of our management and of our manager, RMR;
 
20
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS

considering suggestions for meeting agenda items from other Independent Trustees;

with our Nominating and Governance Committee and Chair of our Board, monitoring and coordinating with our management on corporate governance issues and developments;

authorizing the retention of advisors and consultants who report directly to the Independent Trustees when appropriate; and

if requested, and in coordination with the Chair of our Board and our management, being reasonably available for consultation and direct communication with shareholders.
Code of Business Conduct and Ethics and Committee Governance
   
Our Board is committed to corporate governance that promotes the long term interests of our shareholders. Our Board has established Governance Guidelines that provide a framework for effective governance. Our Board regularly reviews developments in corporate governance and updates our Governance Guidelines and other governance materials as it deems necessary and appropriate.
We have also adopted a Code of Business Conduct and Ethics (the “Code”) to, among other things, provide guidance to our board members, officers and RMR employees and ensure compliance with applicable laws and regulations.
Our Board has an Audit Committee, Compensation Committee and Nominating and Governance Committee. Our Audit Committee, Compensation Committee and Nominating and Governance Committee each have adopted a written charter, and each Board committee reviews its written charter on an annual basis to consider whether any changes are required.
Our corporate governance materials are available for review in the governance section of our website, including our Governance Guidelines, the charter for each Board committee, the Code, information about how to report concerns or complaints about accounting, internal accounting controls or auditing matters and any violations or possible violations of the Code, and how to communicate with our Trustees individually or as a group. To access these documents on our website visit www.dhcreit.com. We intend to satisfy the requirements under Item 5.05 of Form 8-K regarding disclosure of amendments to, or waivers from, provisions of the Code that apply to the principal executive officer, principal financial officer or controller, or persons performing similar functions, by posting such information on our website.
Environmental, Social and Governance Policies
   
Our Board has adopted the following policies in connection with our efforts to lead a sustainable business and to continue to improve our internal culture and the communities in which we operate: Employee Health and Wellness, Human Rights, Philanthropy and Business Partners’ Code of Conduct. These policies reflect our core culture of integrity and mutual respect as well as our commitment to caring for our tenants, residents, guests and the individuals who provide services to us as well as for the communities in which we operate. Our Employee Health and Wellness policy is designed to protect the health and wellbeing of all individuals in our workplace; our Human Rights policy is designed to promote a culture of mutual respect for people, communities and our planet; our Philanthropy policy sets forth our and RMR’s commitment to investing in our communities through a variety of philanthropic engagements; and our Business Partners’ Code of Conduct sets forth our expectations for our and RMR’s business partners to conduct business in an ethical manner that promotes the accomplishment of our goals. For additional information regarding our ESG policies, see the “Sustainability” section beginning on page 6 of this Proxy Statement.
Trustee Resignation Policy
   
Our Governance Guidelines provide that if an incumbent Trustee does not receive a majority of the votes cast in an uncontested election, the Trustee will offer to resign from our Board. In such circumstance, our Nominating and Governance Committee will make a recommendation to our Board on whether to accept or reject the resignation offer, or whether other action should be taken. Our Board will act on the resignation offer taking into account the recommendation of our Nominating and Governance Committee and make its decision within 90 days following the certification of the election results.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
21

TABLE OF CONTENTS
Prohibition on Hedging
   
Our Insider Trading Policies and Procedures expressly prohibit members of our Board and our officers from engaging in hedging transactions involving our securities.
Recommendations for Trustees
   
Shareholders who would like to recommend a Trustee nominee should submit their recommendations in writing by mail to the Chair of our Nominating and Governance Committee, c/o Secretary, Diversified Healthcare Trust, at Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458 or by email to secretary@dhcreit.com. Any such recommendation should include a description of the candidate’s qualifications for Board service, the candidate’s written consent to be considered for nomination and to serve if nominated and elected, as well as the addresses and telephone numbers for contacting the shareholder and the candidate for more information. Our Nominating and Governance Committee may request additional information about the shareholder recommended nominee or about the shareholder recommending the nominee. Recommendations by shareholders will be considered by our Nominating and Governance Committee in its discretion using the same criteria as other candidates it considers.
Communications with Our Board
   
Our Board has established a process to facilitate communication by shareholders and other interested parties with our Trustees, individually or as a group. Communications should be addressed to our Trustees or the Trustee for whom the communication is intended, in care of the Secretary, Diversified Healthcare Trust, Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458 or by email to secretary@dhcreit.com.
Shareholder Nominations and Other Proposals
   
Deadline to Submit Proposals Pursuant to Rule 14a-8 for the 2025 Annual Meeting of Shareholders: Shareholder proposals pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), must be received at our principal executive office on or before November 26, 2024 in order to be eligible to be included in the proxy statement for the 2025 annual meeting of shareholders; provided, that, if the date of the 2025 annual meeting of shareholders is more than 30 days before or after May 31, 2025, such a proposal must be submitted within a reasonable time before we begin to print our proxy materials. Under Rule 14a-8, we are not required to include shareholder proposals in our proxy materials in certain circumstances or if conditions specified in the rule are not met.
Deadline to Submit Trustee Proxy Access Nominations for the 2025 Annual Meeting of Shareholders: Under our proxy access bylaw, a shareholder or a group of up to 20 shareholders owning at least three percent of our outstanding Common Shares continuously for at least three years may nominate and include in our proxy materials for the 2025 annual meeting of shareholders Trustee nominees constituting up to the greater of two nominees or 20% of the number of Trustees serving on our Board. In addition, the shareholder(s) and nominee(s) must satisfy the informational, documentation and other requirements specified by Section 2.18 of our Bylaws. Notice of a proxy access nomination for consideration at our 2025 annual meeting of shareholders must be delivered to or mailed and received at our principal executive office not later than November 26, 2024 and not earlier than October 27, 2024.
Deadline to Submit Other Nominations and Proposals for the 2025 Annual Meeting of Shareholders under our Bylaws: To be timely, shareholder nominations and proposals intended to be made outside of Rule 14a-8 under the Exchange Act and outside of the proxy access bylaw at the 2025 annual meeting of shareholders must be delivered to our Secretary at our principal executive office, in accordance with the requirements of our Bylaws, not later than 5:00 p.m., Eastern time, on November 26, 2024 and not earlier than October 27, 2024; provided, that, if the date of the 2025 annual meeting of shareholders is more than 30 days earlier or later than May 31, 2025, then a shareholder’s notice must be so delivered not later than 5:00 p.m., Eastern time, on the tenth day following the earlier of the day on which (i) notice of the date of the 2025 annual meeting of shareholders is mailed or otherwise made available or (ii) public announcement of the date of
 
22
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
the 2025 annual meeting of shareholders is first made by us. Shareholders making such a nomination or proposal must comply with the advance notice and other requirements set forth in our Bylaws, which include, among other things, requirements as to the shareholder’s timely delivery of advance notice, continuous requisite ownership of Common Shares and holding of a share certificate for such shares at the time of the advance notice, the record date for determining shareholders entitled to vote at the annual meeting and at the time of the annual meeting.
The foregoing description of the deadlines and other requirements for shareholders to submit a nomination for election to our Board or a proposal of other business for consideration at an annual meeting of shareholders is only a summary and is not a complete listing of all requirements. Copies of our Declaration of Trust and Bylaws, including the requirements for proxy access or other shareholder nominations and other shareholder proposals, may be obtained by writing to our Secretary at Diversified Healthcare Trust, Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458, or from the SEC’s website, www.sec.gov. Any shareholder considering making a nomination or proposal should carefully review and comply with those provisions.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
23

TABLE OF CONTENTS
PROPOSAL 1: ELECTION OF TRUSTEES
Upon the recommendation of our Nominating and Governance Committee, our Board has nominated John L. Harrington, Lisa Harris Jones, Phyllis M. Hollis, Dawn K. Neher and Jeffrey P. Somers as Independent Trustees and Christopher J. Bilotto and Adam D. Portnoy as Managing Trustees. Each Trustee nominee currently serves on our Board other than Dawn K. Neher and Christopher J. Bilotto who currently serves as our President and Chief Executive Officer. In connection with Jennifer F. Francis’s resignation as our President and Chief Executive Officer, effective December 31, 2023, and her retirement from the Company and RMR, Ms. Francis is not seeking re-election as a Managing Trustee upon expiration of her current term. Ms. Francis’s decision to not seek re-election to our Board was not due to any disagreement with us relating to our operations, policies or practices. Our Nominating and Governance Committee and our Board voted to nominate Christopher J. Bilotto for election as a Managing Trustee to fill the vacancy created by Ms. Francis’s decision not to seek re-election and Dawn K. Neher for election as an Independent Trustee to fill the vacancy created by the increase in the size of the Board.
If elected, each nominee would serve until our 2025 annual meeting of shareholders and until his, her or their successor is duly elected and qualifies, subject to the individual’s earlier death, resignation, retirement, disqualification or removal.
We expect that each Trustee nominee will be able to serve if elected. However, if a Trustee nominee should become unable or unwilling to serve, proxies may be voted for the election of a substitute nominee designated by our Board.
Board of Trustees’ Qualifications and Experience
Our Trustees have a great diversity of experience and bring to our Board a wide variety of skills, qualifications, viewpoints and backgrounds that strengthen their ability to carry out their oversight role on behalf of our shareholders.
DIVERSITY OF SKILLS AND EXPERIENCES
Risk oversight/management expertise
Familiarity with the public capital markets
Accounting and finance experience, including a high level of financial literacy and understanding of the impact of financial market trends on the real estate industry
Knowledge of the asset management industry, commercial real estate (“CRE”) industry and real estate investment trusts (“REITs”), including medical office, life sciences and senior living markets
Corporate Governance
Understanding of healthcare policy, trends and regulations, and medical office, life science and healthcare business trends
Sustainability
Service on other public company boards and committees
Experience at a strategic or policymaking level
in a business, government, non-profit or
academic organization of high standing
CORE QUALIFICATIONS AND EXPERIENCES
High standards of integrity and ethics
Diverse perspectives, backgrounds and experiences, including professional background, gender, ethnicity and skills
Business acumen, practical wisdom, ability to exercise sound judgment in a congenial manner and ability to make independent analytical inquiries
Commitment to serve on our Board over a period of years in order to develop knowledge about our operations and have sufficient time and availability to devote to Board and committee matters
Strong record of achievements, including work
experience with a proven record of success
 
24
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
[MISSING IMAGE: tb_ourboard-bw.jpg]
Board Diversity Matrix
   
The Nominating and Governance Committee is committed to continuing to identify and recruit highly qualified trustee candidates with diverse experiences, perspectives, and backgrounds to join our Board. The table below provides certain information regarding the composition of our Board as of March 26, 2024. To see our Board diversity matrix as of April 20, 2023, please see the proxy statement for our 2023 annual meeting of shareholders filed with the SEC on April 20, 2023. Each of the categories listed in the below table has the meaning as it is used in Nasdaq Rule 5605(f) and related instructions.
Total Number of Trustees
6
Part I: Gender Identity
Female
Male
Non-Binary
Did Not Disclose
Gender
Trustees
3
3
Part II: Demographic Background
African American or Black
2
Alaskan Native or Native American
Asian
Hispanic or Latinx
Native Hawaiian or Pacific Islander
White
1
3
Two or More Races or Ethnicities
LGBTQ+
Did Not Disclose Demographic Background
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
25

TABLE OF CONTENTS
Snapshot of 2024 Board Nominees
Presented below is a snapshot of the expected composition of our Board immediately following our 2024 Annual Meeting, assuming the election of our Trustee nominees and the expiration of Jennifer F. Francis’s term as a Trustee. Our Board of Trustees believes that, collectively, our Trustees exhibit an effective mix of qualifications, experience and diversity.
[MISSING IMAGE: bc_summary-pn.jpg]
[MISSING IMAGE: tb_tenure-pn.jpg]
A plurality of all the votes cast is required to elect a Trustee at our 2024 Annual Meeting.
The names, principal occupations and certain other information regarding the Trustee nominees that led our Nominating and Governance Committee and our Board to conclude that such persons are currently qualified to serve as Trustees are set forth on the following pages.
Our Board of Trustees recommends a vote “FOR” the election of each of our Trustee nominees.
 
26
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
Trustee Nominees to be Elected at Our 2024 Annual Meeting
   
Christopher J. Bilotto, 46, Nominee for Managing Trustee
[MISSING IMAGE: ph_christopherjbilotto-bw.jpg]
TRUSTEE NOMINEE
PRESIDENT AND CHIEF EXECUTIVE OFFICER SINCE 2024
BOARD COMMITTEES

None
PROFESSIONAL EXPERIENCE:

Our President and Chief Executive Officer since January 2024.
Executive Vice President of RMR since 2023, where he is responsible for portfolio management oversight for all properties managed by RMR LLC, design, construction, development and redevelopment across the United States, oversight of acquisitions and dispositions, and senior living and hotel asset management. Prior to that, Mr. Bilotto served as Senior Vice President of RMR from 2020 to 2023 and Vice President from 2016 to 2020 after joining RMR in 2011. Mr. Bilotto’s prior responsibilities at RMR included serving as Senior Area Director of RMR LLC’s West Region.
Former chief executive officer of Office Properties Income Trust from October 2023 to December 2023, president from 2021 to December 2023, chief operating officer from 2020 to 2023 and vice president from 2019 to 2020.
Previously held various management roles for shopping malls and mixed-use assets in New Mexico, Arizona and California at General Growth Properties.

Member of the National Association of Office and Industrial Properties.
OTHER RMR PUBLIC CLIENT BOARDS(1):

None
OTHER NON-RMR MANAGED PUBLIC COMPANY BOARDS:

None
QUALIFICATIONS
Mr. Bilotto brings to our Board extensive professional skills and demonstrated management ability. Mr. Bilotto has experience in, and knowledge of, REITs and experience working in the CRE industry. Mr. Bilotto possesses institutional knowledge earned through prior service as an officer of Office Properties Income Trust and in leadership positions with RMR. Mr. Bilotto has professional skills and expertise in real estate matters and experience as a senior level executive officer. Mr. Bilotto identifies as Caucasian and as male. Mr. Bilotto qualifies as a Managing Trustee in accordance with the requirements of our governing documents.
Risk Oversight/Management
Financial Literacy
Human Capital Management
Investment Expertise
REIT/Real Estate
ESG
Public Company Executive
(1)
In addition to us, RMR or its subsidiaries currently provide management services to four other public companies that do not have any employees of their own: Industrial Logistics Properties Trust (Nasdaq: ILPT), Office Properties Income Trust (Nasdaq: OPI), Service Properties Trust (Nasdaq: SVC) and Seven Hills Realty Trust (Nasdaq: SEVN). For us and the companies with no employees, RMR or its subsidiaries provide all business operations and functions pursuant to the terms of the applicable management agreements with those companies.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
27

TABLE OF CONTENTS
John L. Harrington, 87, Independent Trustee
[MISSING IMAGE: ph_johnharrington-bw.jpg]
TRUSTEE SINCE 1999
BOARD COMMITTEES

Audit (Chair)
PROFESSIONAL EXPERIENCE:
Chairman of the board of trustees of the Yawkey Foundation (a charitable foundation) since 2007 and from 2002 to 2003.

Trustee of the Yawkey Foundation since 1982 and executive director from 1982 to 2006.

Trustee of the JRY Trust from 1982 through 2009.
Chief executive officer and general partner of the Boston Red Sox Baseball Club from 1986 to 2002 and vice president and chief financial officer prior to 1986.

President of Boston Trust Management Corp. from 1981 to 2006.

Principal of Bingham McCutchen Sports Consulting LLC from 2007 to 2008.
Represented the Boston Red Sox majority interest in co-founding The New England Sports Network, managing it from 1981 to 2002.

Director of Fleet Bank from 1995 to 1999.

Director of Shawmut Bank of Boston from 1986 to 1995.

Member of the Major League Baseball Executive Council from 1998 to 2001.
Assistant secretary of administration and finance for the Commonwealth of Massachusetts in 1980.

Treasurer of the American League of Professional Baseball Clubs from 1970 to 1972.
Assistant professor and director of admissions, Carroll Graduate School of Management at Boston College from 1967 through 1970.

Supervisory auditor for the U.S. General Accounting Office from 1961 through 1966.

Many civic leadership positions.

Recipient of numerous leadership awards and honorary doctorate degrees.

Licensed as a certified public accountant in Massachusetts.
OTHER RMR PUBLIC CLIENT BOARDS(1):

Service Properties Trust (since 1995)

Office Properties Income Trust (since 2009)
Seven Hills Realty Trust (then known as RMR Mortgage Trust and prior to that as RMR Real Estate Income Fund (and its predecessors)) (from 2003 to 2021)

Tremont Mortgage Trust (from 2017 to 2021)
OTHER NON-RMR MANAGED PUBLIC COMPANY BOARDS:

None
QUALIFICATIONS
Mr. Harrington brings to our Board extensive professional skills and leadership experience. Mr. Harrington has held key management roles in various enterprises and has worked on public company boards as well as board committees. Mr. Harrington has served on the boards of several private and charitable organizations. Mr. Harrington possesses extensive experience in, and knowledge of, accounting, finance, risk management, compensation and benefits. Mr. Harrington also has experience as a chief executive officer and a chief financial officer. Mr. Harrington has institutional knowledge earned through prior service on our Board. Mr. Harrington identifies as Caucasian and as male. Mr. Harrington qualifies as an Independent Trustee in accordance with the requirements of the Nasdaq, the SEC and our governing documents.
Risk Oversight/Management
Human Capital Management
Financial Expertise
Public Company Board
REIT/Real Estate
ESG
Government/Public Policy
 
28
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
Lisa Harris Jones, 56, Independent Trustee
[MISSING IMAGE: ph_lisaharris-bw.jpg]
TRUSTEE SINCE 2015
LEAD INDEPENDENT TRUSTEE SINCE DECEMBER 2018
BOARD COMMITTEES

Audit
Compensation
Nominating and Governance
PROFESSIONAL EXPERIENCE:
Founding and managing member of Harris Jones & Malone, LLC, a Maryland based law firm that focuses on state and local lobbying, government relations and procurement, since 2000.
Practiced corporate securities, mergers and acquisitions, government relations, real estate financing and land use law at other Maryland law firms, prior to founding Harris Jones & Malone, LLC.
Worked in a pro bono capacity for dyslexia education, community development in Baltimore City’s most challenging areas, and the advancement of minority and women business enterprises.
Served in leadership positions on several non-profit boards, including the Baltimore Museum of Art and Everyman Theatre.
Recognized for both her professional and civic work by multiple entities including Savoy Magazine where she gained national recognition by being named one of the Most Influential Black Corporate Directors.
OTHER RMR PUBLIC CLIENT BOARDS(1):

Industrial Logistics Properties Trust (since 2018)
TravelCenters of America Inc. (from 2013 until it was acquired by BP Products North America Inc. in May 2023)
OTHER NON-RMR MANAGED PUBLIC COMPANY BOARDS:

None
QUALIFICATIONS
Ms. Harris Jones brings to our Board extensive professional skills and experience in legal and business finance matters, public policy and real estate matters. Ms. Harris Jones has dedicated a great deal of her time and resources to matters of public interest. Ms. Harris Jones’s practice includes representation of small and large business enterprises, both publicly and privately held, municipalities and related quasi-public agencies, and nonprofit organizations. Ms. Harris Jones represents clients on a wide range of business interests’ concerns including, but not limited to, public and private real estate development, land use zoning and financing, construction, energy, retail sales, education, transportation, public safety, healthcare, gaming, telecommunications, intellectual technology, procurement, corporate, taxation, labor and employment, insurance, public interest, election, and environmental law. Ms. Harris Jones has demonstrated leadership capacity as an entrepreneur and founding member of a law firm. Ms. Harris Jones has served on public company boards and board committees and possesses institutional knowledge earned through prior service on our Board. Ms. Harris Jones identifies as African American and as female. Ms. Harris Jones qualifies as an Independent Trustee in accordance with the requirements of the Nasdaq, the SEC and our governing documents.
Risk Oversight/Management
Financial Literacy
Public Company Board
Investment Expertise
Legal/Regulatory
Human Capital Management
ESG
REIT/Real Estate
Government/Public Policy
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
29

TABLE OF CONTENTS
Phyllis M. Hollis, 68, Independent Trustee
[MISSING IMAGE: ph_phyllishollis-bw.jpg]
TRUSTEE SINCE 2023
BOARD COMMITTEES

Audit
Compensation (Chair)
PROFESSIONAL EXPERIENCE:

Chief executive officer of Hollis Advisory LLC since 2018.
Chief executive officer, chief marketing officer and chief operating officer for CAVU Securities, LLC, a New York based investment bank from 2014 to 2018.

Founded and served as president of Egerie Consulting from 2000 until 2010.

Co-founded Utendahl Capital Partners, a minority owned investment bank, in 1994.
Serves on the finance and investment committee for Guild Hall, a community arts, entertainment and education center.
Trustee on several other non-profit company boards, mostly involved with the visual arts, and serves on various committees which include strategic planning, investments/finance, impact initiatives and marketing.
Launched a weekly podcast, Cerebral Women Art Talks, to promote and provide marketing services to visual artists, mainly artists of color, female artists and art professionals, in 2020.
OTHER RMR PUBLIC CLIENT BOARDS(1):

Seven Hills Reality Trust (from 2022 to September 2023)
OTHER NON-RMR MANAGED PUBLIC COMPANY BOARDS:

None
QUALIFICATIONS
Ms. Hollis brings to our Board extensive experience in, and knowledge of, the investment banking industry and demonstrated management ability. Additionally, Ms. Hollis brings to our Board her experience in capital raising and strategic business transactions, as well as her professional training, skills and expertise in finance matters. Ms. Hollis identifies as African American and as female. Ms. Hollis qualifies as an Independent Trustee in accordance with the requirements of the Nasdaq, the SEC and our governing documents.
Risk Oversight/Management
Human Capital Management
Financial Literacy
Investment Expertise
ESG
 
30
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
Dawn K. Neher, 67, Nominee for Independent Trustee
[MISSING IMAGE: ph_dawnkneher-bw.jpg]
TRUSTEE NOMINEE
BOARD COMMITTEES

None(2)
PROFESSIONAL EXPERIENCE:

Principal of Back East Consulting LLC since 2013.
Chief financial officer and director at large of Cambridge Innovation Centers from 2019 to 2021.

Chief financial officer of New England Development from 1998 to 2013.
Executive vice president, finance and acquisitions of New England Development from 1995 to 1998.
Vice president of equity investments of Aetna Realty Investors (now UBS Realty Investors) from 1986 to 1989.
Member of the corporate board committee of the Boston Club since to 2013 and director at large from 2013 to 2016.

Member of National Association of Corporate Directors since 2013.

Legacy council member of Commercial Real Estate Women since 2012.

Member and panel speaker for International Council of Shopping Centers since 1989.

Member of the Pension Real Estate Association since 2010.
Member of the Urban Mixed Used Development Council since 2019 and member of the Urban Land Institute since 1989.
OTHER RMR PUBLIC CLIENT BOARDS(1):

None
OTHER NON-RMR MANAGED PUBLIC COMPANY BOARDS:

None
QUALIFICATIONS
Ms. Neher brings to our Board demonstrated management ability and extensive professional skills and experience in finance and real estate matters as a senior level executive officer. Ms. Neher has extensive experience in, and knowledge of, the CRE industry and over 35 years of experience working in real estate development, management and financing. Ms. Neher identifies as Caucasian and as female. Ms. Neher qualifies as an Independent Trustee in accordance with the requirements of the Nasdaq, the SEC and our governing documents.
Risk Oversight/Management
Financial Literacy
Human Capital Management
Investment Expertise
REIT/Real Estate
ESG
(2)
Ms. Neher may be appointed to one or more of the Board’s committees following our 2024 Annual Meeting, assuming her election as an Independent Trustee.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
31

TABLE OF CONTENTS
Adam D. Portnoy, 53, Managing Trustee
[MISSING IMAGE: ph_adamdportnoy-bw.jpg]
TRUSTEE SINCE 2007
CHAIR OF OUR BOARD SINCE 2019
BOARD COMMITTEES

None
PROFESSIONAL EXPERIENCE:

President and Chief Executive Officer of RMR Inc., since shortly after its formation in 2015.
President and Chief Executive Officer of RMR since 2005, and Director from 2006 to June 5, 2015 when RMR became a majority owned subsidiary of RMR Inc. and RMR Inc. became RMR’s managing member.

Director of Tremont Realty Capital LLC since March 2016.

Sole trustee, controlling shareholder and an officer of ABP Trust.
Director and controlling shareholder of Sonesta International Hotels Corporation and its parent.

Sole director of AlerisLife, Inc. since its acquisition by ABP Trust in March 2023.
Director of RMR Advisors LLC from 2007 to 2021 when it merged with Tremont Realty Capital LLC.
Served in various positions in the finance industry and public sector, including working as an investment banker at Donaldson, Lufkin & Jenrette and working in private equity at DLJ Merchant Banking Partners and at the International Finance Corporation (a member of The World Bank Group).
Founded and served as chief executive officer of a privately financed telecommunications company.

Honorary Consul General of the Republic of Bulgaria to Massachusetts.

Member of Massachusetts Opportunity Alliance, Inc. Board.

Member of Massachusetts High Technology Council, Inc. Board.

Chair of the board of directors of the Pioneer Institute.
Executive committee member of the board of directors of the Greater Boston Chamber of Commerce.

Member of AJC New England’s Leadership Board.
Previously served on the board of governors for the National Association of Real Estate Investment Trusts and the board of trustees of Occidental College.
OTHER RMR PUBLIC CLIENT BOARDS(1):

Service Properties Trust (since 2007)

Office Properties Income Trust (since 2009)

Seven Hills Realty Trust, including its predecessor companies (since 2009)

The RMR Group Inc. (since 2015)

Industrial Logistics Properties Trust (since 2017)
TravelCenters of America Inc. (from 2018 until it was acquired by BP Products North America Inc. in May 2023) and chair of its board (from 2019 to May 2023)
AlerisLife Inc. (from 2018 until it was acquired by ABP Trust in March 2023) and chair of its board (from 2019 to March 2023)
Tremont Mortgage Trust (from 2017 until it merged with Seven Hills Realty Trust in September 2021)
OTHER NON-RMR MANAGED PUBLIC COMPANY BOARDS:

None
QUALIFICATIONS
Mr. Portnoy brings to our Board extensive experience in, and knowledge of, the asset management and CRE industries and REITs, gained in part through his key leadership position with RMR and its subsidiaries, his public company board service, and his demonstrated management ability. Mr. Portnoy also possesses experience in investment banking and private equity, as well as institutional knowledge earned through prior service on our Board and deep knowledge of our business. Mr. Portnoy identifies as Caucasian and as male. Mr. Portnoy qualifies as a Managing Trustee in accordance with the requirements of our governing documents.
Our Nominating and Governance Committee and our Board believe that, because Mr. Portnoy is the president and chief executive officer of RMR and the business of all the companies (including our Company) for which he serves as a managing trustee or managing director is integral to his day to day work, service on these additional boards does not impair the amount of attention or time that Mr. Portnoy spends on service on our Board. Our Board believes that Mr. Portnoy’s extensive familiarity with our day to day business provides valuable insight for our Board.
Risk Oversight/Management
Human Capital Management
Financial Literacy
Public Company Board
REIT/Real Estate
Investment Expertise
ESG
Public Company Executive
Government/Public Policy
 
32
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
Jeffrey P. Somers, 81, Independent Trustee
[MISSING IMAGE: ph_jeffreysomers-bw.jpg]
TRUSTEE SINCE 2009
LEAD INDEPENDENT TRUSTEE FROM 2015-2018
BOARD COMMITTEES

Audit
Compensation
Nominating and Governance (Chair)
PROFESSIONAL EXPERIENCE:
Of counsel since 2010, and member of the law firm of Morse, Barnes-Brown & Pendleton, PC from 1995 to 2009, serving as managing member for six of those years.
Former partner at the law firm of Gadsby Hannah LLP (now McCarter & English, LLP) for more than 20 years prior to working at Morse, Barnes-Brown & Pendleton, PC, serving as managing partner for eight of those years.
Director of Cantella Management Corp., a holding company of Cantella & Co., Inc., an SEC registered broker-dealer, from 2002 until January 2014, when the company was acquired by a third party.

Trustee of the Pictet Funds from 1995 to 2001.

Former staff attorney at the SEC in Washington, D.C. prior to entering private law practice.
Former trustee of Glover Hospital, a private not for profit regional hospital, which is currently part of Beth Israel Deaconess Hospital, among various other civic leadership roles.
OTHER RMR PUBLIC CLIENT BOARDS(1):

Office Properties Income Trust (since 2009)

Seven Hills Realty Trust including its predecessor companies (since 2009)

Tremont Mortgage Trust (from 2017 to 2020)
Select Income REIT (from 2012 until it merged with a wholly owned subsidiary of Office Properties Income Trust in December 2018)
OTHER NON-RMR MANAGED PUBLIC COMPANY BOARDS:

None
QUALIFICATIONS
Mr. Somers brings to our Board extensive expertise in legal, corporate governance and regulatory matters, as well as leadership experience gained from his role as a law firm managing partner. Mr. Somers also possesses a sophisticated understanding of finance and accounting matters, obtained through his service as a trustee of public REITs and investment companies, as well as work on board committees. Mr. Somers has extensive experience in public policy matters and complex business transactions gained partly from government service, as well as institutional knowledge earned through prior service on our Board. Mr. Somers identifies as Caucasian and as male. Mr. Somers qualifies as an Independent Trustee in accordance with the requirements of the Nasdaq, the SEC and our governing documents.
Risk Oversight/Management
Human Capital Management
Financial Literacy
REIT/Real Estate
ESG
Legal/Regulatory
Government/Public Policy
Public Company Board
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
33

TABLE OF CONTENTS
Executive Officers
   
Our executive officers serve at the discretion of our Board. There are no family relationships among any of our Trustees or executive officers.
[MISSING IMAGE: ph_christopherjbilotto-bw.jpg]
Christopher J. Bilotto
Age: 46
President and Chief Executive Officer since 2024
Mr. Bilotto’s background and qualifications are described above.
[MISSING IMAGE: ph_matthewcbrown-bw.jpg]
Matthew C. Brown
Age: 42
Chief Financial Officer and Treasurer since 2023
Mr. Brown has been a Senior Vice President of RMR since 2019 and has served in various finance and accounting leadership roles with RMR and its subsidiaries since 2007, including currently being responsible for the day to day oversight of the accounting and finance support functions and the tax department of RMR and various affiliates. Mr. Brown served as chief financial officer and treasurer of Office Properties Income Trust from 2019 until September 2023. Mr. Brown is a certified public accountant. Mr. Brown identifies as Caucasian and as male.
 
34
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
BOARD COMMITTEES
Audit Committee
   
Members
John L. Harrington (Chair)
Lisa Harris Jones
Phyllis M. Hollis
Jeffrey P. Somers
8 meetings during 2023
Our Audit Committee is comprised solely of Independent Trustees. Its primary role is to help our Board fulfill its oversight responsibilities related to the integrity of our financial statements and financial reporting process, the qualifications, independence and performance of our independent registered public accounting firm, the performance of our internal audit function, risk management and our compliance with legal and regulatory requirements. Our Audit Committee is responsible for the appointment, compensation, retention and oversight, and the evaluation of the qualifications, performance and independence, of our independent auditor and the resolution of disagreements between management and our independent auditor. Our independent auditor reports directly to our Audit Committee. Our Audit Committee reviews the overall audit scope and plans of the audit with our independent auditor. Our Audit Committee also reviews with management and our independent auditors our quarterly reports on Form 10-Q, annual reports on Form 10-K and earnings releases.
Our Board has determined that each member of our Audit Committee is financially literate and that Mr. Harrington is our Audit Committee’s “financial expert.”
Mr. LePage served as the Chair of our Audit Committee and Mr. Pierce served as a member of our Audit Committee until their resignations from our Board on September 25, 2023.
Compensation Committee
   
Members
Phyllis M. Hollis (Chair)
Lisa Harris Jones
Jeffrey P. Somers
6 meetings during 2023
Our Compensation Committee is comprised solely of Independent Trustees. Its primary responsibilities pertain to evaluating the performance and compensation of RMR and our executive officers, evaluating and approving any changes in our agreements with RMR and approving equity compensation awards. Our Compensation Committee recommends to our Board the cash compensation payable to our Trustees for Board and committee service. Our Compensation Committee determines and approves the equity based compensation payable to our Trustees for Board and committee service, and any compensation payable to the Lead Independent Trustee in his, her or their capacity as such. Our Compensation Committee administers our Share Award Plan and determines all awards granted pursuant to the Share Award Plan. It also reviews amounts payable by us to RMR under our business and property management agreements and approves any proposed amendments to or termination of those agreements.
Mr. Somers served as the Chair of our Compensation Committee until September 26, 2023. Mr. Pierce served on our Compensation Committee until his resignation from our Board on September 25, 2023.
Nominating and Governance Committee
   
Members
Jeffrey P. Somers (Chair)
Lisa Harris Jones
3 meetings during 2023
Our Nominating and Governance Committee is comprised solely of Independent Trustees. Its primary role is to identify individuals qualified to become Board members, consistent with criteria approved by our Board, and to recommend candidates to our entire Board for nomination or selection as Board members for each annual meeting of shareholders or when vacancies occur, to perform certain assessments of our Board and Board committees, including to assess the independence of Trustees and Trustee nominees, and to develop and recommend to our Board governance principles for our Company. Under its charter, our Nominating and Governance Committee is also responsible for considering and reporting on our succession planning to our Board.
Mr. Harrington served as Chair of our Nominating and Governance Committee until September 26, 2023.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
35

TABLE OF CONTENTS
BOARD MEETINGS
In 2023, our Board held 13 meetings. In 2023, each then Trustee attended 75% or more of the aggregate of all meetings of our Board and the committees on which he, she or they served or that were held during the period in which the Trustee served as a Trustee or committee member. All of the then Trustees attended last year’s annual meeting of shareholders. Our policy with respect to Board members’ attendance at meetings of our Board and annual meetings of shareholders can be found in our Governance Guidelines, the full text of which appears at our website, www.dhcreit.com.
TRUSTEE COMPENSATION
Compensation of Trustees
   
Our Board believes that competitive compensation arrangements are necessary to attract and retain qualified Independent Trustees. Under the currently effective Trustee compensation arrangements, each Independent Trustee receives an annual fee of $85,000 for services as a Trustee. The annual fee for any new Independent Trustee is prorated for the initial year. Each Independent Trustee who serves as a committee chair of our Audit Committee, Compensation Committee or Nominating and Governance Committee also receives an additional annual fee of $20,000, $15,000 and $15,000, respectively, and our Lead Independent Trustee also receives an additional annual fee of $17,500 for serving in this role. Trustees who serve as the chair or a member of a special committee receive an additional fee. Trustees are reimbursed for travel expenses they incur in connection with their duties as Trustees and for out of pocket costs they incur in connection with their attending certain continuing education programs.
Each Independent Trustee and Managing Trustee also receives an award of Common Shares annually, which was 20,000 Common Shares in 2023. Managing Trustees do not receive cash compensation for their services as Trustees.
Trustee Share Ownership Guidelines
   
Our Board believes it is important to align the interests of our Trustees with those of our shareholders, and for our Trustees to hold equity ownership positions in our Company. Accordingly, each Trustee is expected to retain at least 100,000 Common Shares (which number shall automatically adjust in respect of stock splits or similar events) within the following times: (i) for persons serving as Trustees as of June 3, 2021, by the date of our 2025 annual meeting of shareholders, and (ii) for persons elected as Trustees after June 3, 2021 if such person initially became a Trustee by election by our shareholders, by the date of the annual meeting of shareholders held in the fourth year following the annual meeting of shareholders at which such Trustee was initially elected; or if such person initially became a Trustee by election by our Board, by the date of our annual meeting of shareholders in the fourth year following the first annual meeting of shareholders of our Company following the initial election of such Trustee to our Board. Any Trustee who is prohibited by law or by applicable regulation of his, her or their employer from owning equity in our Company is exempt from this requirement. Our Nominating and Governance Committee may consider whether exceptions should be made for any Trustee on whom this requirement could impose a financial hardship.
As of March 22, 2024, all Trustees have met or, within the applicable period, are expected to meet, these share ownership guidelines.
 
36
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
Fiscal Year 2023 Trustee Compensation
   
The following table details the total compensation of the Trustees for the fiscal year ended December 31, 2023 for services as a Trustee.
Name
Fees Earned or Paid
in Cash ($)
(1)
Stock Awards ($)(2)
All Other
Compensation ($)
Total ($)
Jennifer F. Francis(3)(4) 34,800 34,800
John L. Harrington 103,466 34,800 138,266
Lisa Harris Jones 152,500 34,800 187,300
Phyllis M. Hollis(5) 69,316 44,600 113,916
Daniel F. LePage(6) 130,000 34,800 164,800
David A. Pierce(6) 110,000 34,800 144,800
Adam D. Portnoy(3) 34,800 34,800
Jeffrey P. Somers 100,000 34,800 134,800
(1)
The amounts reported in the Fees Earned or Paid in Cash column reflect the cash fees earned by each Independent Trustee in 2023, consisting of an $85,000 annual cash fee and each of Messrs. Harrington, LePage and Somers and Ms. Hollis earned an additional $18,466, $20,000, $15,000 and $10,398, respectively, for service as a committee chair in 2023. Ms. Harris Jones earned an additional $17,500 for service as the Lead Independent Trustee. Messrs. LePage and Pierce also received $25,000 for serving on the special committee of our Board, which was comprised solely of Independent Trustees, in connection with the negotiations relating to the proposed merger of our Company and Office Properties Income Trust during 2023, and Ms. Harris Jones received $50,000 for her role as chair of this special committee.
(2)
Equals 20,000 Common Shares multiplied by the closing price of such shares on June 5, 2023, the award date, other than with respect to Ms. Hollis whose award of 20,000 Common Shares in connection with her election to the Board was multiplied by the closing price of such shares on September 26, 2023, the award date. Amounts shown are also the compensation cost for the award recognized by us for financial reporting purposes pursuant to Financial Accounting Standards Board Accounting Standards CodificationTM Topic 718, “Compensation—Stock Compensation” ​(“ASC 718”) (which equals the closing price of the shares on the award date, multiplied by the number of shares subject to the award). No assumptions were used in this calculation. All Common Share awards fully vested on the award date.
(3)
Managing Trustees do not receive cash compensation for their services as Trustees.
(4)
In connection with her resignation as our President and Chief Executive Officer, effective December 31, 2023, and her retirement from the Company and RMR, effective July 1, 2024, Ms. Francis entered into a Retirement Agreement, dated November 15, 2023, pursuant to which she agreed to continue to serve as a Managing Trustee until the earliest of (i) our 2024 Annual Meeting, (ii) July 1, 2024 or (iii) as requested by RMR or our Board.
(5)
Ms. Hollis received a prorated fee of $58,918 for a partial year of service as an Independent Trustee beginning with her election to our Board on September 26, 2023.
(6)
Messrs. LePage and Pierce resigned as Independent Trustees on September 25, 2023.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
37

TABLE OF CONTENTS
OWNERSHIP OF OUR EQUITY SECURITIES
Trustees and Executive Officers
   
The following table sets forth information regarding the beneficial ownership of the outstanding Common Shares by each Trustee nominee, each Trustee, each of our named executive officers and our Trustees, Trustee nominees, and executive officers as a group, all as of March 22, 2024. Unless otherwise noted, to our knowledge, voting power and investment power in the Common Shares are exercisable solely by the named person and the principal business address of the named person is c/o Diversified Healthcare Trust, Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458.
Name and Address
Aggregate
Number of
Shares
Beneficially
Owned*
Percent of
Outstanding
Shares**
Additional Information
Adam D. Portnoy 23,464,392
9.76%
Includes 23,250,019 Common Shares
owned by ABP Trust. Voting and
investment power with respect to Common
Shares owned by ABP Trust may be
deemed to be shared by Adam D. Portnoy
as ABP Trust’s sole trustee.
Jennifer F. Francis(1) 256,153
Less than 1%
Jeffrey P. Somers 98,500
Less than 1%
Lisa Harris Jones 90,297
Less than 1%
Richard W. Siedel Jr.(2) 88,791
Less than 1%
John L. Harrington 60,000
Less than 1%
Includes 60,000 Common Shares owned by the John L. Harrington Revocable Trust. Mr. Harrington may be deemed to hold voting and investment power as a trustee and beneficiary of the John L. Harrington Revocable Trust.
Matthew C. Brown 50,171
Less than 1%
Christopher J. Bilotto 48,666
Less than 1%
Phyllis M. Hollis 20,000
Less than 1%
Dawn K. Neher 0
Less than 1%
All Trustees, the Trustee nominees and executive officers as a group (nine persons) 24,088,179
10.02%
*
Amounts exclude fractional shares.
**
The percentages indicated are based on approximately 240,418,363 Common Shares outstanding as of March 22, 2024.
(1)
Ms. Francis resigned as our President and Chief Executive Officer, effective December 31, 2023.
(2)
Mr. Siedel resigned as our Chief Financial Officer and Treasurer, effective September 30, 2023.
 
38
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
Principal Shareholders
   
Set forth in the table below is information about the number of Common Shares held by persons known to be the beneficial owners of more than 5.0% of the outstanding Common Shares based on filings with the SEC pursuant to Section 13(d) and Section 13(g) of the Exchange Act.
Name and Address
Aggregate
Number of
Shares
Beneficially
Owned
Percent of
Outstanding
Shares*
Additional Information
Flat Footed LLC (“Flat Footed”)
3465 N Pines Way, Suite 104 Box 206 Wilson, WY 83014
23,487,000 9.77%
Based on a Schedule 13D filed with the SEC on
December 22, 2023 by Flat Footed reporting that
at December 19, 2023, Flat Footed beneficially
owned 23,487,000 Common Shares and had
shared voting power over 23,487,000 Common
Shares and shared dispositive power over
23,487,000 Common Shares.
ABP Trust and
Adam D. Portnoy
Two Newton Place
255 Washington Street
Suite 300
Newton, Massachusetts 02458
23,250,019 9.67% Based on a Schedule 13D filed with the SEC on
June 20, 2023 by Mr. Portnoy and ABP Trust,
reporting that, as of June 7, 2023, (i) ABP Trust
beneficially owned 23,250,019 Common Shares
and had shared voting and dispositive power
over 23,250,019 Common Shares and
(ii) Adam D. Portnoy directly owned and had
sole voting and dispositive power over
214,373.55 Common Shares, beneficially
owned 23,464,392.55 Common Shares and had
shared voting and dispositive power over
23,250,019 Common Shares.
The Vanguard Group, Inc. (“Vanguard”)
100 Vanguard Boulevard
Malvern, Pennsylvania 19355
20,078,770 8.35% Based on a Schedule 13G/A filed with the SEC
on February 13, 2024 by Vanguard reporting
that, at December 29, 2023, Vanguard
beneficially owned 20,078,770 Common Shares
and had shared voting power over 145,087
Common Shares, sole dispositive power over
19,752,286 Common Shares and shared
dispositive power over 326,484 Common
Shares.
BlackRock, Inc. (“BlackRock”)
55 East 52nd Street
New York, New York 10055
18,689,085 7.77% Based on a Schedule 13G/A filed with the SEC
on January 26, 2024 by BlackRock reporting
that, at December 31, 2023, BlackRock
beneficially owned 18,689,085 Common Shares
and had sole voting power over 18,247,074
Common Shares and sole dispositive power
over 18,689,085 Common Shares.
Silver Point Capital, L.P.
(“Silver Point”)
Two Greenwich Plaza
Suite 1
Greenwich, CT 06830
15,720,000 6.54% Based on a Schedule 13G filed with the SEC on
February 14, 2024 by Silver Point reporting that,
at December 31, 2023, Silver Point beneficially
owned 15,720,000 Common Shares and had
shared voting power over 15,720,000 Common
Shares and shared dispositive power over
15,720,000 Common Shares.
H/2 Special Opportunities IV L.P.
(“H/2”)
680 Washington Boulevard, 7th Floor
Stamford, CT 06901
14,917,366 6.20% Based on a Schedule 13D filed on June 30, 2023 by H/2 reporting that at June 30, 2023, H/2 beneficially owned 14,917,366 Common Shares and had shared voting power over 14,917,366 Common Shares and shared dispositive power over 14,917,366 Common Shares.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
39

TABLE OF CONTENTS
Name and Address
Aggregate
Number of
Shares
Beneficially
Owned
Percent of
Outstanding
Shares*
Additional Information
Charles Schwab Investment Management, Inc. (“Charles Schwab”)
211 Main Street
San Francisco, CA 94105
14,346,995 5.97% Based on a Schedule 13G filed with the SEC on
February 9, 2024 by Charles Schwab reporting
that, at December 31, 2023, Charles Schwab
beneficially owned 14,346,995 Common Shares
and had sole voting power over 14,346,995
Common Shares and sole dispositive power
over 14,346,995 Common Shares.
D.E. Shaw & Co., L.P.
(“DESCO”)
1166 Avenue of the Americas, 9
th Floor
New York, New York 10036
13,768,926 5.73% Based on a Schedule 13D filed on October 5,
2023 by DESCO reporting that at
September 29, 2023, DESCO beneficially
owned 13,768,926 Common Shares and had
shared voting power over 13,768,926 Common
Shares and shared dispositive power over
13,768,926 Common Shares.
*
Our Declaration of Trust places restrictions on the ability of any person or group to acquire beneficial ownership of more than 9.8% of any class of our Common Shares. Vanguard, however, is an Excepted Holder, as defined in our Declaration of Trust, and therefore is not subject to this ownership limit, subject to certain limitations. Additionally, on November 1, 2023, we amended our Bylaws to provide that transfers of our Common Shares to a person or group which is then, or would become as a result, owners of 5% or more of our outstanding Common Shares would be void in total for transferees then already owning 5% or more of our shares, and for transferees that would otherwise become owners of 5% or more of our Common Shares, to the extent the transfer would so result in such level of ownership by the proposed transferee. Common Shares relating to attempted transfers in violation of this prohibition may be subject to transfer to a charitable trust in accordance with the provisions of our Declaration of Trust. With respect to shareholders who held in excess of 5% of our Common Shares outstanding prior to November 1, 2023, none of such shareholders’ Common Shares were deemed under the new limitation to be excess securities subject to automatic transfer to a charitable trust; instead such shareholders will not be permitted to acquire additional Common Shares while owning 5% or more of our outstanding Common Shares or thereafter to the extent any such subsequent acquisition would result in them owning 5% or more of our outstanding Common Shares. The ownership limitation in our Bylaws is intended to help us preserve the tax treatment of our net operating losses and other tax benefits.
The percentages indicated are based on approximately 240,418,363 Common Shares outstanding as of March 22, 2024.
 
40
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
PROPOSAL 2:
ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION
As required by Section 14A of the Exchange Act, we are seeking a non-binding advisory vote from our shareholders to approve the compensation of our named executive officers as described in the “Compensation Discussion and Analysis” section beginning on page 42 and the “Executive Compensation” section beginning on page 48.
Our Board recommends that shareholders vote “FOR” the following resolution:
RESOLVED: That the shareholders of the Company approve, on a non-binding, advisory basis, the compensation paid by the Company to the Company’s named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the “Compensation Discussion and Analysis” in this Proxy Statement.
Because your vote is advisory, it will not be binding upon our Board or Compensation Committee. However, our Board values shareholders’ opinions and our Compensation Committee will take into account the outcome of the vote when considering future executive compensation decisions.
Approval of the advisory vote to approve executive compensation requires the affirmative vote of a majority of all the votes cast, in person or by proxy, at our 2024 Annual Meeting.
Our Board of Trustees recommends a vote “FOR” the advisory vote to approve executive compensation.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
41

TABLE OF CONTENTS
COMPENSATION DISCUSSION AND ANALYSIS
Compensation Overview
   
Our compensation structure is unique because of our relationship with our manager, RMR. Our business management agreement with RMR is designed to incentivize RMR to provide the highest quality services to us. RMR’s base business management fee is paid based on the lower of the historical cost of our properties and our market capitalization. RMR also may earn an incentive management fee based on the three year total return of our Common Shares relative to an index of our peers. Because our named executive officers are employees of RMR and not our Company, RMR, and not our Company, determines the cash compensation payable to our named executive officers.1 We do not reimburse RMR for compensation RMR paid or pays to our executive officers and our management agreements with RMR do not require RMR to allocate or pay a specific amount or percentage of RMR’s management fees to our named executive officers or require those officers to dedicate a specified amount of their time to our business.
RMR Compensation Practices. In order to enable our shareholders to make an informed decision on the non-binding advisory vote to approve the compensation of our named executive officers (“Say on Pay”), RMR has provided us with the following information about the compensation it paid in 2023 to our named executive officers for services provided by those officers to RMR, our Company and other RMR Clients:

The portion of the management fee that is allocated to named executive officer compensation paid by RMR.

Of this named executive officer compensation, the breakdown of base salary vs. cash bonus.

The metrics RMR uses to evaluate performance to determine the named executive officers’ cash bonuses.
Our named executive officers are officers and employees of RMR and, as officers and employees of RMR, also provide services to RMR and other RMR Clients. RMR has informed us that the cash compensation paid by RMR to our named executive officers is for services provided by the officers to RMR, our Company and other RMR Clients. RMR has also informed us that it is not able to allocate with reasonable certainty or provide a reasonable estimate of the compensation paid by RMR to our named executive officers for their services to us for a number of reasons, including that:

Our management agreements with RMR do not require individual executive officers to dedicate a specific amount of time to providing services to us under those agreements. RMR’s officers and employees provide services on an as needed basis across RMR, our Company and all other RMR Clients.

Our management agreements with RMR do not require that a specified amount or percentage of the management fees we pay to RMR be allocated to our executive officers.

RMR does not designate a specific amount of time that our named executive officers must spend providing services to us or record the amount of time that our named executive officers (or any other employee of RMR) spend providing services to us or other entities.
Summary of 2023 Named Executive Officer Compensation.

RMR has advised us that in 2023, RMR paid each of our named executive officers cash compensation for services provided by the officers to RMR, our Company and other RMR Clients, which cash compensation was comprised of a base salary and a discretionary cash bonus. With respect to 2023, our named executive officers collectively received aggregate base salary payments of $1,100,000 and Ms. Francis and Mr. Brown collectively received aggregate discretionary cash bonuses of $2,075,000 from RMR. These amounts collectively represent 7.7% of the aggregate management fees and reimbursements we paid to RMR for 2023. On an aggregated basis, Ms. Francis and
1
Our named executive officers were our only executive officers during 2023. Ms. Francis resigned as our President and Chief Executive Officer, effective December 31, 2023, and Mr. Bilotto was elected as our President and Chief Executive Officer, effective January 1, 2024. Mr. Siedel resigned as our Chief Financial Officer and Treasurer, effective September 30, 2023, and Mr. Brown was elected as our Chief Financial Officer and Treasurer, effective October 1, 2023. Although some of our named executive officers served as our executive officers for only a part of 2023, the cash compensation information described in this Proxy Statement includes the cash compensation RMR paid to each of them for the full year.
 
42
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
Mr. Brown received 35% of their total 2023 cash compensation in the form of base salary payments and the remaining 65% in the form of discretionary cash bonuses. Mr. Siedel did not receive a cash bonus from RMR in 2023. In connection with his resignation as our Chief Financial Officer and Treasurer and as a senior vice president of RMR, effective September 30, 2023, Mr. Siedel received a cash payment from RMR of $400,000 pursuant to his separation agreement with RMR. Mr. Siedel is eligible to receive an additional payment of $450,000 from RMR subject to other customary terms and conditions, including his compliance with confidentiality, non-solicitation, and other covenants and execution of a waiver and release of RMR and the Company.

RMR did not provide guaranteed cash bonuses to our named executive officers during 2023 and did not set specific performance targets on which bonuses would be payable to them. Instead, the annual cash bonuses paid by RMR to Ms. Francis and Mr. Brown in 2023 were discretionary in amount and were based on a performance evaluation conducted by, in the case of Ms. Francis, RMR Inc.’s compensation committee and, in the case of Mr. Brown, certain members of RMR’s Executive Operating Committee.

In 2023, RMR Inc. awarded 6,000 shares of Class A common stock of RMR Inc., with a grant date fair value of $148,740, to Ms. Francis and 2,400 shares of Class A common stock of RMR Inc., with a grant date fair value of $59,496 to Mr. Brown (subject to certain vesting requirements described below). The award to Mr. Brown was made in his capacity as an officer of RMR prior to the time he became an executive officer of our Company. Mr. Siedel did not receive an award of shares of Class A common stock of RMR Inc. in 2023.

A list of specified peer companies was considered by RMR to develop appropriate compensation packages for the named executive officers.
Named Executive Officer Compensation Philosophy and Process.
The key principle of RMR’s compensation philosophy for all employees, including our named executive officers, is to pay for performance. RMR maintains a rigorous and thorough talent and compensation review process to ensure that its employees are in appropriate roles that maximize their full potential. This process also ensures that there is strong leadership guiding employees and that there is a succession and development plan for each role. RMR’s goal is to make employee and leadership development an integral part of its culture, supporting each employee and the continued success of RMR, our Company and other RMR Clients.
[MISSING IMAGE: box_key-pn.jpg]
RMR’s named executive officer compensation planning process incorporates key areas of evaluation, including:

external market data;

internal benchmarking; and

quantitative and qualitative assessments of Company, group and individual performance.
Named Executive Officer Compensation Practices. RMR’s pay for performance compensation philosophy is reflected in its compensation practices, including:

no guaranteed salary increases or guaranteed cash bonuses;

no specific performance targets on which bonuses would be paid;

no specific incentive or additional performance awards for growing assets under management or for exceeding return benchmarks;

no excessive perquisites;

no tax gross-ups;

annual assessment of named executive officer compensation against peer companies and best practices;

holistic performance evaluations; and

annual salary cap.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
43

TABLE OF CONTENTS
Components of the Named Executive Officers’ Compensation. RMR’s compensation program includes both a base salary and a cash bonus. The cash bonuses RMR pays to our named executive officers are discretionary in amount and are based on a performance evaluation. The evaluation involves an analysis of both (i) the overall performance of RMR, our Company and other RMR Clients, and (ii) the performance of the individual officer and his, her or their contributions, and services provided, to RMR, our Company and other RMR Clients. RMR believes this evaluation process allows RMR to link pay with performance in the closest way possible and provide RMR with the flexibility necessary to take all relevant factors into account in determining the bonus amounts, including the named executive officer’s ability to react to changing circumstances that impact the businesses of RMR, our Company and other RMR Clients.
RMR Inc. also awards shares of Class A common stock of RMR Inc. to our named executive officers. One fifth of the shares awarded vested on the award date and an additional one fifth are scheduled to vest on each of the next four anniversaries of the award date, subject to the applicable named executive officer continuing to render significant services to RMR or one or more of the RMR Clients or their respective affiliates and to accelerated vesting under certain circumstances.
The table below describes the objectives supported by each of RMR’s and RMR Inc.’s primary compensation elements, along with an overview of the key design features of each element.
Compensation Element
What It Does
Key Measures
Base Salary

Provides a level of fixed pay appropriate to an executive’s role and responsibilities

Evaluated on an annual basis

Experience, duties and scope of responsibility

Internal and external market factors
Discretionary Cash Bonus

Provides a competitive annual cash incentive opportunity

Links executives’ interests with shareholders’ interests

Incentivizes and rewards superior group, individual and Company performance

Based on holistic performance evaluation
Equity Compensation

Links executives’ interests with long-term interests of shareholders

Incentivizes and rewards superior group, individual and Company performance

Based on holistic performance evaluation
Named Executive Officer Pay Mix. As discussed above, RMR’s compensation program is designed so that the majority of compensation is performance based to promote alignment of our named executive officers’ interests with those of shareholders. During 2023, Ms. Francis and Mr. Brown received aggregate performance based discretionary cash bonuses of $2,075,000 from RMR. Mr. Siedel did not receive a cash bonus from RMR in 2023. In connection with his resignation as our Chief Financial Officer and Treasurer and as a senior vice president of RMR, effective September 30, 2023, Mr. Siedel received a cash payment from RMR of $400,000 pursuant to his separation agreement with RMR. Mr. Siedel is eligible to receive an additional payment of $450,000 from RMR subject to other customary terms and conditions, including his compliance with confidentiality, non-solicitation, and other covenants and execution of a waiver and release of RMR and the Company.
The base salary payments for our named executive officers (which represent the fixed portion of their compensation packages) are reviewed annually and may be adjusted as RMR deems appropriate. RMR historically adjusts salary payments on October 1, the first day of its fiscal year. During 2023, Ms. Francis and Messrs. Brown and Siedel received aggregate base salary payments of $1,100,000 from RMR. On an aggregated basis, in 2023, Ms. Francis and Mr. Brown received 35% of their total cash compensation in the form of base salary payments and the remaining 65% in the form of performance-based discretionary bonuses.
For information regarding the compensation paid by RMR and RMR Inc. to the named executive officers of RMR Inc., please see the documents filed by RMR Inc. with the SEC, including its Annual Report on Form 10-K
 
44
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
for the fiscal year ended September 30, 2023 and its Proxy Statement on Schedule 14A for its 2024 Annual Meeting of Shareholders. RMR Inc.’s filings with the SEC are not incorporated by reference into this Proxy Statement.
Compensation Philosophy
   
Our compensation program for our executive officers consists of Common Share awards under the Share Award Plan. Our Compensation Committee believes that these share awards recognize our executive officers’ scope of responsibilities, reward demonstrated performance and leadership, motivate future performance and further align the interests of the executive officers with those of our shareholders.
Overview of 2023 Compensation Actions
   
In September 2023, our Compensation Committee Chair met with one of our Managing Trustees, Adam D. Portnoy, and the compensation committee chairs of RMR Inc. and the other RMR Clients, which included: Industrial Logistics Properties Trust (“ILPT”); Office Properties Income Trust (“OPI”); Service Properties Trust (“SVC”); and Seven Hills Realty Trust (“SEVN” and, together with ILPT, OPI and SVC, the “Other RMR Managed REITs”). The purposes of this meeting were, among other things, to discuss compensation philosophy and factors that may affect compensation decisions, to consider the allocation of internal audit and related services costs among RMR Inc., our Company and other RMR Clients, to provide a comparative understanding of potential share awards by us and the Other RMR Managed REITs and to hear and consider recommendations from RMR concerning potential share awards and the vesting of those shares, which were in part based on the results of RMR’s review of current market practices with respect to executive compensation, and specifically of the companies’ peer groups, and shareholder feedback received during shareholder outreach with respect to the percentage of executive officer compensation received in share awards. The share awards made by the Other RMR Managed REITs are considered to be appropriate comparisons because of the similarities between certain services we require from our share awardees and the services provided by awardees providing similar services to these other companies. Subsequent to this meeting, the members of our Compensation Committee held a meeting at which our Compensation Committee Chair provided a report of the information discussed with Mr. Portnoy and others, and made recommendations for share awards to our named executive officers. Our Compensation Committee then discussed these recommendations and other factors, including the following factors for the 2023 share awards: (i) the value of the proposed share awards; (ii) the historical awards previously awarded to these named executive officers and the corresponding values at the time of the awards; (iii) the recommendations of RMR as presented by Mr. Portnoy, president and chief executive officer of RMR; (iv) the value of share awards to executive officers providing comparable services at the applicable Other RMR Managed REITs and other RMR Clients; (v) the scope of, and any changes to, the responsibilities assigned to, or assumed by, these named executive officers during the past year and on a going forward basis; (vi) the length of historical services by these named executive officers; (vii) our Compensation Committee’s perception regarding the quality of the services provided by these named executive officers in carrying out those responsibilities; and (viii) our financial and operating performance in the past year and our perceived future prospects. Our Compensation Committee considered these multiple factors in determining whether to increase or decrease the amounts of the prior year’s awards. There was no formulaic approach in the use of these various factors in determining the number of shares to award to each named executive officer. The share amounts we awarded were determined by our Compensation Committee on a discretionary basis using various factors. The named executive officers did not participate in these meetings and were not involved in determining or recommending the amount or form of named executive officer compensation they received from us.
Analysis of 2023 Awards under the Share Award Plan
   
Although we do not pay any cash compensation directly to our officers and have no employees, we adopted the Share Award Plan to reward our named executive officers and other RMR employees who provide services to us and to align their interests with those of our shareholders. We award shares under the Share Award Plan to recognize our named executive officers’ scope of responsibilities, reward demonstrated performance and leadership, motivate future performance, align the interests of our executives with those of our other
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
45

TABLE OF CONTENTS
shareholders and motivate the executives to remain employees of RMR and to continue to provide services to us through the term of the awards.
Under its charter, our Compensation Committee evaluates, approves and administers our equity compensation plans, which currently consist solely of the Share Award Plan. Our Compensation Committee has historically determined to use awards of Common Shares under the Share Award Plan rather than seek to issue stock options as equity compensation. Because the value of the Common Shares may be determined in part by reference to its dividend yield relative to market interest rates rather than by its potential for capital appreciation, we believe a conventional stock option plan might not provide appropriate incentives for management for a business like ours, but a share award plan may create a better identity of interests between management and other shareholders. Also, because we believe a stock option plan could have the potential to encourage excessive short term risk taking, we have historically granted share awards rather than issue stock options.
Our Compensation Committee uses comparative information about the applicable Other RMR Managed REITs as additional data to help it determine whether it is awarding share amounts that are reasonable based on the characteristics of those REITs and their respective officers. Our Compensation Committee also considers the size and structure of the applicable Other RMR Managed REITs and other RMR Clients, and the experience, length of service and scope of duties and responsibilities of the officers at these other companies to assess the appropriateness of the value of the share awards proposed for our officers in light of the proposed awards for officers with comparable roles at the other companies. Our Compensation Committee reviewed the compensation data regarding the applicable Other RMR Managed REITs and their officers, together with the other factors discussed above in “Overview of 2023 Compensation Actions,” but our Compensation Committee did not undertake a detailed comparison of the named executive officers across the applicable Other RMR Managed REITs or other RMR Clients or assign weight to any particular characteristic of these other companies or their officers because our Compensation Committee determines the share amounts in its sole discretion on a non-formulaic basis. In 2023, our Compensation Committee considered the foregoing factors and the factors set forth above in “Overview of Fiscal 2023 Compensation Actions” and decided to award the same number of Common Shares to Ms. Francis that she received in 2022. The award to Mr. Brown of Common Shares in 2023 was in his capacity as an officer of RMR prior to his becoming our executive officer. Mr. Siedel did not receive an award of Common Shares in 2023. Our Compensation Committee considered Ms. Francis level of performance and length of service to us in determining her award. Her share award was made in accordance with the recommendation of RMR and the Chair of our Compensation Committee. Such share award also provides for vesting upon the occurrence of certain corporate “change in control” or termination events.
We determine the fair market value of the shares awarded based on the closing price of the Common Shares on the date of the award. Our Compensation Committee has imposed, and may impose, vesting and other conditions on the awarded Common Shares because it believes that time based vesting encourages the recipients of the share awards to remain employed by RMR and to continue to provide services to us. Our Compensation Committee currently uses a vesting schedule under which one fifth of the shares vest immediately and the remaining shares vest in four equal, consecutive annual installments commencing on the first anniversary of the date of the award. Our Compensation Committee utilizes a four year time based vesting schedule to provide an incentive to provide services for a long term and in consideration of the tax treatment of the share awards to us and to the recipients. In the event a recipient who received a share award ceases to render significant services, whether as an employee or otherwise, to us, RMR or any RMR Client or their respective affiliates during the vesting period, we may cause the forfeiture of the Common Shares that have not yet vested. As with other issued Common Shares, vested and unvested shares awarded under the Share Award Plan are entitled to receive distributions that we make, if any, on the Common Shares.
Because the consideration of share awards by our Compensation Committee and our Board is determined on a regular schedule (i.e., in September for our officers and employees of RMR and at the first meeting of our Board after the annual meeting of shareholders for the Trustees), any proximity of any awards to earnings announcements or other market events is coincidental.
Our Compensation Committee believes that its compensation philosophy and programs are designed to foster a business culture that aligns the interests of its named executive officers with those of its shareholders.
 
46
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
Our Compensation Committee believes that the equity compensation of its named executive officers is appropriate to the goal of providing shareholders dependable, long term returns.
Frequency of Say on Pay
   
Our current policy, consistent with the prior vote of our shareholders, is to provide shareholders with an opportunity to approve, on an advisory basis, our compensation of our named executive officers each year at the annual meeting of shareholders. Accordingly, we are providing shareholders with an opportunity to approve this compensation on a non-binding, advisory basis. As noted above, our only compensation paid by us to our named executive officers is Common Share awards. None of our named executive officers are employed by us. Our manager, RMR, provides services that otherwise would be provided by employees and employs and compensates our named executive officers directly and in RMR’s sole discretion in connection with their services rendered to us and to RMR and the other RMR Clients as discussed above.
In evaluating our compensation process for 2023, our Compensation Committee generally considered the results of the most recent advisory vote of our shareholders on the compensation of the executive officers named in the proxy statement for our 2023 annual meeting of shareholders.
As noted above, Section 14A of the Exchange Act requires that we provide an opportunity for our shareholders to indicate how frequently we should hold the non-binding advisory vote on the compensation paid to our named executive officers. This “frequency” vote is required to be held at least once every six years. We last held a “frequency” vote at our 2023 annual meeting of shareholders. At that meeting, our shareholders voted in favor of holding annual advisory votes on the compensation of our named executive officers. Our next “frequency” vote is expected to be held at the 2029 annual meeting of shareholders.
REPORT OF OUR COMPENSATION COMMITTEE
The Compensation Committee (our “Compensation Committee”) of the Board of Trustees (our “Board of Trustees”) of Diversified Healthcare Trust has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K with management. Based on such review and discussions, our Compensation Committee recommended to our Board of Trustees that the Compensation Discussion and Analysis be included in this Proxy Statement and incorporated by reference into the Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
Phyllis M. Hollis, Chair
Lisa Harris Jones
Jeffrey P. Somers
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
Our Compensation Committee is comprised entirely of the three Independent Trustees listed above. No member of our Compensation Committee is a current, or during 2023 was a former, officer or employee of ours. In 2023, none of our executive officers served (i) on the compensation committee of any entity that had one or more of its executive officers serving on our Board or our Compensation Committee or (ii) on the board of directors or board of trustees of any entity that had one or more of its executive officers serving on our Compensation Committee. Members of our Compensation Committee serve or served as independent trustees and compensation committee members of other public RMR Clients. Mr. Somers serves as an independent trustee of OPI and SEVN. Ms. Harris Jones serves as an independent trustee of ILPT and served as an independent director and a member of the compensation committee of TravelCenters of America Inc. until May 2023. Ms. Hollis served as an independent trustee and a member of the compensation committee of SEVN until her resignation from the SEVN board of trustees on September 25, 2023. The disclosures regarding our relationships with these foregoing entities and certain transactions with or involving them under the section entitled “Certain Related Person Transactions” are incorporated by reference herein.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
47

TABLE OF CONTENTS
EXECUTIVE COMPENSATION
The following tables and footnotes summarize the total compensation we paid to our former President and Chief Executive Officer, our Chief Financial Officer and Treasurer, and our former Chief Financial Officer and Treasurer, or our “named executive officers.” As discussed in further detail above, Jennifer F. Francis resigned as our President and Chief Executive Officer, effective December 31, 2023, and Christopher J. Bilotto was elected as our President and Chief Executive Officer, effective January 1, 2024. Richard W. Siedel resigned as our Chief Financial Officer and Treasurer, effective September 30, 2023. Our named executive officers were our only executive officers during 2023. Please see “Compensation Discussion and Analysis—Compensation Overview” above for an explanation of why we pay our named executive officers no cash compensation. For information regarding the compensation paid by RMR and RMR Inc. to our named executive officers, please see the above “RMR Compensation Practices” section. For information regarding the compensation paid by RMR and RMR Inc. to the named executive officers of RMR Inc., please see the documents filed by RMR Inc. with the SEC, including its Annual Report on Form 10-K for the fiscal year ended September 30, 2023 and its Proxy Statement on Schedule 14A for its 2024 Annual Meeting of Shareholders. RMR Inc.’s filings with the SEC are not incorporated by reference into this Proxy Statement.
Summary Compensation Table
   
Name and Principal Position
Year
Salary
Bonus
Stock Awards ($)(1)
All Other
Compensation ($)
(2)
Total ($)
Jennifer F. Francis(3)(4)
Former President and Chief
Executive Officer
2023
174,600 4,110 178,710
2022
120,800 3,195 123,995
2021
278,600 1,824 280,424
Matthew C. Brown(3)(5)
Chief Financial Officer and Treasurer
2023
34,950 1,030 35,980
2022
2021
Richard W. Siedel Jr.(3)(6)
Former Chief Financial Officer and Treasurer
2023
2,200 2,200
2022
52,000 1,845 53,845
2021
102,300 1,189 103,489
(1)
Represents the grant date fair value of Common Share awards in 2023, 2022 and 2021, as applicable, calculated in accordance with ASC 718 (which equals the closing price of the shares on the award date, multiplied by the number of shares subject to the award). No assumptions were used in this calculation. The values listed in this column for Ms. Francis include the value of 20,000 Common Shares awarded to her in her capacity as a Managing Trustee in 2023, 2022 and 2021. Ms. Francis was first elected as a Managing Trustee in June 2021 and she was also elected Chief Executive Officer at that time and continued to serve as our President. Prior to that time, she served as our President and Chief Operating Officer.
(2)
Consists of cash distributions in the applicable year on unvested Common Shares received in connection with cash distributions we paid to all of our shareholders. We pay no cash compensation to our executive officers. As noted above, our named executive officers are employees of, and are paid by, RMR for their service as our executive officers (other than the awards of Common Shares described in this Proxy Statement for their service as our executive officers, or with respect to Mr. Brown in 2023, for his service as an officer of RMR).
(3)
Our named executive officers are officers and employees of RMR, and as officers and employees of RMR, also provide services to RMR and RMR Clients. In 2023, our named executive officers received aggregate base salary payments of $1,100,000 and Ms. Francis and Mr. Brown received aggregate cash bonuses of $2,075,000 from RMR for services those officers provided to RMR, our Company and other RMR Clients. Mr. Siedel did not receive a cash bonus from RMR in 2023. In connection with his resignation as our Chief Financial Officer and Treasurer and as a senior vice president of RMR, effective September 30, 2023, Mr. Siedel received a cash payment from RMR of $400,000 pursuant to his separation agreement with RMR. Mr. Siedel is eligible to receive an additional payment of $450,000 from RMR subject to other customary terms and conditions, including his compliance with confidentiality, non-solicitation, and other covenants and execution of a waiver and release of RMR and the Company.
(4)
Ms. Francis resigned as our President and Chief Executive Officer, effective December 31, 2023. In connection with her resignation, Ms. Francis entered into a retirement agreement with RMR. For more information regarding this agreement, please see RMR’s proxy statement on Schedule 14A for its 2024 annual meeting of shareholders. Mr. Bilotto was appointed President and Chief Executive Officer, effective January 1, 2024.
(5)
Only one year of information has been provided for Mr. Brown because he was not a named executive officer prior to 2023.
(6)
Mr. Siedel resigned as our Chief Financial Officer and Treasurer, effective September 30, 2023.
 
48
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
2023 Grants of Plan Based Awards
   
The following table shows the total Common Shares awarded by us to our named executive officers in their capacity as our officers in 2023, other than for Mr. Brown who was awarded these Common Shares in his capacity as an officer of RMR.
Name
Grant Date
All Other Stock Awards:
Number of Shares of
Stock or Units (#)
Grant Date Fair Value of
Stock and Option
Awards ($)
(1)
Jennifer F. Francis 9/13/2023 60,000 139,800
Matthew C. Brown 9/13/2023 15,000 34,950
Richard W. Siedel Jr.(2)
(1)
Equals the number of Common Shares awarded multiplied by the closing price on the date of the award, which is also the grant date fair value under ASC 718. No assumptions were used in this calculation.
(2)
Mr. Siedel resigned as our Chief Financial Officer and Treasurer, effective September 30, 2023 and did not receive an award of Common Shares during 2023.
2023 Outstanding Equity Awards at Fiscal Year End
   
The agreements governing the Common Shares we awarded to our named executive officers in 2023 and prior years in their capacity as our officers provided that one fifth of each award vested on the date of the award and an additional one fifth vests on each of the next four anniversaries of the award date, subject to the applicable named executive officer continuing to render significant services, whether as an employee or otherwise, to us, RMR or any RMR Client or their respective affiliates and to accelerated vesting under certain circumstances. Holders of vested and unvested Common Shares awarded under the Share Award Plan receive distributions that we make, if any, on our shares on the same terms as other holders of the Common Shares.
The following table shows the total Common Shares awarded by us in 2023 and prior years to our named executive officers that were unvested as of December 31, 2023.
Stock Awards
Name
Year Granted
Number of Shares or Units
of Stock That Have Not
Vested (#)
(1)
Market Value of Shares or
Units of Stock That Have
Not Vested ($)
(2)
Jennifer F. Francis
2023 48,000 179,520
2022 36,000 134,640
2021 24,000 89,760
2020 6,000 22,440
Matthew C. Brown(3)
2023 12,000 44,880
2022 9,000 33,660
2021 6,000 22,440
2020 1,600 5,984
Richard W. Siedel Jr.(4)
2023
2022 24,000 89,760
2021 12,000 44,880
2020 4,000 14,960
(1)
The Common Shares awarded in 2023, 2022, 2021 and 2020 were awarded on September 13, 2023, September 14, 2022, September 15, 2021 and September 17, 2020, respectively.
(2)
Equals the number of Common Shares not vested multiplied by the closing price of the Common Shares on December 29, 2023.
(3)
Mr. Brown was appointed as our Chief Financial Officer and Treasurer, effective October 1, 2023. The Common Shares awarded to Mr. Brown in 2023 and prior years were awarded to him in his capacity as an officer and employee of RMR before becoming an executive officer of our Company.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
49

TABLE OF CONTENTS
(4)
In connection with Mr. Siedel’s resignation as our Chief Financial Officer and Treasurer and separation from RMR, our Compensation Committee approved the acceleration of the vesting of his unvested Common Shares, effective June 30, 2024, the date of his separation from RMR.
2023 Stock Vested
   
The following table shows Common Share awards made in 2023 and prior years to our named executive officers that vested in 2023.
Stock Awards
Name
Number of Shares Acquired
on Vesting (#)
Value Realized on
Vesting ($)
(1)
Jennifer F. Francis(2) 45,000 106,770
Matthew C. Brown(3) 11,200 26,574
Richard W. Siedel Jr.(4) 20,000 47,920
(1)
Equals the number of vesting Common Shares multiplied by the closing price on the dates that such Common Shares vested in 2023.
(2)
The number of Common Shares shown in the table does not include Common Shares awarded to Ms. Francis in her capacity as a Managing Trustee.
(3)
The Common Shares awarded to Mr. Brown in 2023 and prior years were awarded to him in his capacity as an officer and employee of RMR.
(4)
In connection with Mr. Siedel’s resignation as our Chief Financial Officer and Treasurer, effective September 30, 2023 and his separation from RMR, our Compensation Committee approved the acceleration of the vesting of Mr. Siedel’s unvested Common Shares, effective June 30, 2024, the date of his separation from RMR.
Potential Payments upon Termination or Change in Control
   
The Share Award Plan and the form of share award agreement for awards made to our named executive officers provides for acceleration of vesting of all share awards upon the occurrence of certain change in control or termination events (each, a “Termination Event”). The following table describes the potential payments to our named executive officers upon a Termination Event, if such event had occurred, as of December 31, 2023.
Name
Number of Shares Vested Upon
Termination Event (#)
Value Realized on Termination Event
as of December 31, 2023 ($)
(1)
Jennifer F. Francis 114,000 426,360
Matthew C. Brown 28,600 106,964
Richard W. Siedel Jr.(2) 40,000 149,600
(1)
Equals the number of Common Shares multiplied by the closing price of the Common Shares on December 29, 2023.
(2)
In connection with Mr. Siedel’s resignation as our Chief Financial Officer and Treasurer, effective September 30, 2023, and his separation from RMR, our Compensation Committee approved the acceleration of the vesting of Mr. Siedel’s unvested Common Shares, effective June 30, 2024, the date of his separation from RMR.
From time to time we have approved, and may in the future approve, the acceleration of vesting of Common Shares previously awarded under the Share Award Plan to former employees of RMR, which may include individuals who are our executive officers, when their employment with RMR is terminated.
For a discussion of the consequences of a Termination Event under our business and property management agreements with RMR, see the below “Related Person Transactions” section.
Pay Ratio
   
Pay ratio disclosure under Item 402(u) has not been provided because we do not have any employees.
 
50
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
Pay Versus Performance
   
The following table and footnotes summarize the total compensation we paid to our Named Executive Officers (our “NEOs”), compensation “actually paid” to the NEOs (calculated in accordance with SEC rules), the cumulative total shareholder return of the Company, the peer group total shareholder return and our net income for the past four fiscal years. We do not use any financial performance measures to link compensation actually paid to our NEOs by us to the Company’s performance. Accordingly, pursuant to the SEC rules, we have not included a “company selected measure” or the tabular list of performance measures. Please see “Compensation Discussion and Analysis—Compensation Overview” above for an explanation of why we pay our NEOs no cash compensation. For information regarding the compensation paid by RMR and RMR Inc. to our NEOs, please see the above “RMR and RMR Inc. Compensation Practices section.
Pay Versus Performance
Year
Summary
Compensation
Table Total for
Principal
Executive
Officer (“PEO”)
Compensation
Actually Paid
to PEO
(1)
Average
Summary
Compensation
Table Total for
Non-PEO NEOs
Average
Compensation
Actually Paid
to Non-PEOs
NEOs
(2)(3)
Value of Initial Fixed $100
Investment Based on:
Net Income
(Loss)
($000s)
Total
Shareholder
Return
Peer Group
Total
Shareholder
Return**
2023
$178,710 $508,007 $19,090 $139,720 $50.07 $92.56 $(293,572)
2022
123,995 (75,701)* 53,845 (61,296)* 8.38 81.72 (15,774)
2021
280,424 231,125 103,489 71,960 39.15 104.54 179,926
2020
116,421 58,298 78,157 27,432 51.69 90.08 (134,307)
*
Because the Company does not pay cash compensation to its NEOs, the total compensation from the summary compensation table does not include cash compensation received by our NEOs. The negative values for Compensation Actually Paid in 2022 reflect the decline in value of the share awards granted by us to our NEOs.
**
Peer group total shareholder return is based on the MSCI U.S. REIT/ Health Care REIT Index.
(1)
The following table summarizes the applicable deductions and additions for the PEO in the calculation of Compensation Actually Paid to the PEO.
PEO Compensation Actually Paid
Year
PEO Name
Total
Compensation
Per Summary
Compensation
Table Less
Stock Grant
Amount
Year End
Fair Value
of Equity
Awards
Granted and
Unvested
During
Applicable
Year
Change in
Fair Value
as of Year
End of Any
Prior Year
Awards that
Remain
Unvested as
of Year End
Awards
Granted and
Vested in
the Same
Year, at Fair
Value as of
the Vesting
Date
Change in
Fair Value
as of Year
End of Any
Prior Year
Awards that
Vested
During
Applicable
Year
Total
Equity Value
Reflected in
Compensation
Actually Paid
Compensation
Actually Paid
to PEO
2023
Jennifer F. Francis
$4,110 $179,520 $204,151 $62,760 $57,466 $503,897 $508,007
(2)
The only non-PEO NEOs for 2023 are Richard W. Siedel and Matthew C. Brown.
(3)
The following table summarizes the applicable deductions and additions for each of the non-PEO NEOs in the calculation of Compensation Actually Paid to each non-PEO NEO.
Average Non-PEO NEOs—Compensation Actually Paid
Year
Total
Compensation
Per Summary
Compensation
Table Less
Stock Grant
Amount
Year End
Fair Value
of Equity
Awards
Granted and
Unvested
During
Applicable
Year
Change in
Fair Value
as of Year
End of Any
Prior Year
Awards that
Remain
Unvested as
of Year End
Awards
Granted and
Vested in
the Same
Year, at Fair
Value as of
the Vesting
Date
Change in
Fair Value
as of Year
End of Any
Prior Year
Awards that
Vested
During
Applicable
Year
Total
Equity Value
Reflected in
Compensation
Actually Paid
Compensation
Actually Paid to
Non-PEO NEOs
2023
$1,615
$22,440
$87,538
$3,495
$24,632
$138,105
$139,720
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
51

TABLE OF CONTENTS
Relationship Description
[MISSING IMAGE: bc_tsr-4c.jpg]
[MISSING IMAGE: bc_netincome-4c.jpg]
*
Because the Company does not pay cash compensation to its NEOs, the total compensation from the summary compensation table does not include cash compensation received by our NEOs. The negative values for Compensation Actually Paid in 2022 reflect the decline in value of the share awards granted by us to our NEOs.
 
52
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
[MISSING IMAGE: lc_peergroup-4c.jpg]
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
53

TABLE OF CONTENTS
PROPOSAL 3:
RATIFICATION OF THE APPOINTMENT OF
DELOITTE & TOUCHE LLP AS INDEPENDENT AUDITORS
Our Audit Committee has the sole authority and responsibility to hire, evaluate and, when appropriate, replace our independent auditors and is directly responsible for the appointment, compensation and general oversight of the work of our independent auditors. Our Audit Committee is responsible for approving the audit and permissible non-audit services provided by our independent auditors and the associated fees.
Our Audit Committee evaluates the performance of our independent auditors annually and determines whether to re-engage the current independent auditors or consider other audit firms. In doing so, our Audit Committee considers the quality and efficiency of the services provided by the auditors, the auditors’ technical expertise and knowledge of our operations and industry, the auditors’ independence, the results of inspections by the Public Company Accounting Oversight Board (“PCAOB”) and peer quality reviews of the auditors and the auditors’ reputation in the marketplace. In connection with the mandated rotation of our independent auditors’ lead engagement partner, our Audit Committee and its Chair consider the selection of the new lead engagement partner identified by our independent auditors.
Based on this evaluation, our Audit Committee has appointed Deloitte & Touche LLP (“Deloitte”) to serve as our independent auditors for the fiscal year ending December 31, 2024. Deloitte has served as our independent auditors since June 2020 and is considered by management and our Audit Committee to be well-qualified.
Our Audit Committee has determined to submit its selection of our independent auditors to our shareholders for ratification. This vote will ratify prior action by our Audit Committee and will not be binding upon our Audit Committee. However, our Audit Committee may reconsider its prior appointment of our independent auditors or consider the results of this vote when it determines who to appoint as our independent auditors in the future.
Audit Fees and All Other Fees
   
The following table shows the fees for audit and other services provided to us by Deloitte for the fiscal years ended December 31, 2023 and 2022.
2023 Fees
2022 Fees
Audit Fees $ 1,514,850 $ 1,403,477
Audit Related Fees 31,200
Tax Fees 21,000 28,350
All Other Fees 948 948
Audit Fees. This category includes fees associated with the annual financial statements audit and related audit procedures, the audit of internal control over financial reporting, work performed in connection with any registration statements and any applicable Current Reports on Form 8-K and the review of any of our Quarterly Reports on Form 10-Q.
Audit Related Fees. This category consists of services that are reasonably related to the performance of the audit or review of financial statements and are not included in “Audit Fees.” These services principally include due diligence in connection with acquisitions, consultation on accounting and internal control matters, audits in connection with proposed or consummated acquisitions, information systems audits and other attest services.
Tax Fees. This category consists of fees for tax services, including tax compliance, tax advice and tax planning.
All Other Fees. This category consists of services that are not included in the above categories. The amounts for 2023 and 2022 reflect annual subscription fees for Deloitte’s online accounting research application.
 
54
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditors
   
Our Audit Committee has established policies and procedures that are intended to control the services provided by our independent auditors and to monitor their continuing independence. Under these policies, our independent auditors may not undertake any services unless the engagement is specifically approved by our Audit Committee or the services are included within a category that has been approved by our Audit Committee. The maximum charge for services is established by our Audit Committee when the specific engagement or the category of services is approved. In certain circumstances, our management is required to notify our Audit Committee when approved services are undertaken and our Audit Committee or its Chair may approve amendments or modifications to the engagement or the maximum fees. RMR’s internal audit group is responsible for reporting to our Audit Committee regarding compliance with these policies and procedures.
Our Audit Committee will not approve engagements of our independent auditors to perform non-audit services for us if doing so will cause our independent auditors to cease to be independent within the meaning of applicable SEC or Nasdaq rules. In other circumstances, our Audit Committee considers, among other things, whether our independent auditors are able to provide the required services in a more or less effective and efficient manner than other available service providers and whether the services are consistent with the PCAOB’s rules.
All services for which we engaged Deloitte in fiscal 2023 and 2022 were approved by our Audit Committee. The total fees for audit and non-audit services provided by Deloitte in fiscal 2023 and 2022 are set forth above. Our Audit Committee approved the engagement of Deloitte in fiscal 2023 and 2022 to provide the non-audit services described above because it determined that Deloitte providing these services would not compromise Deloitte’s independence and that Deloitte’s familiarity with our record keeping and accounting systems would permit it to provide these services with equal or higher quality, more quickly and at a lower cost than we could obtain comparable quality services from other providers.
Other Information
   
We have been advised by Deloitte that neither the firm, nor any member of the firm, has any material interest, direct or indirect, in any capacity in us or our subsidiaries.
One or more representatives of Deloitte will be present at our 2024 Annual Meeting. The representatives will have an opportunity to make a statement if they desire to do so and will be available to respond to appropriate questions.
Ratification of the appointment of our independent auditors requires the affirmative vote of a majority of all the votes cast, in person or by proxy, at our 2024 Annual Meeting.
Our Board of Trustees recommends a vote “FOR” the ratification of the appointment of Deloitte & Touche LLP as independent auditors.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
55

TABLE OF CONTENTS
REPORT OF OUR AUDIT COMMITTEE
In the course of the Audit Committee (our “Audit Committee”) of the Board of Trustees (our “Board of Trustees”) of Diversified Healthcare Trust’s oversight of our financial reporting process, our Audit Committee has: (i) reviewed and discussed with management the audited financial statements for the fiscal year ended December 31, 2023; (ii) discussed with Deloitte & Touche LLP, our independent auditors, the matters required to be discussed under Public Company Accounting Oversight Board (the “PCAOB”) Auditing Standard No. 1301; (iii) received the written disclosures and the letter from our auditors required by applicable requirements of the PCAOB regarding our independent auditors’ communications with our Audit Committee concerning independence; (iv) discussed with our independent auditors their independence; and (v) considered whether the provision of non-audit services by our independent auditors is compatible with maintaining their independence and concluded that it is compatible at this time.
Based on the foregoing review and discussions, our Audit Committee recommended to our Board of Trustees that the audited financial statements be included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023, for filing with the Securities and Exchange Commission.
John L. Harrington, Chair
Lisa Harris Jones
Phyllis M. Hollis
Jeffrey P. Somers
 
56
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
FREQUENTLY ASKED QUESTIONS
Proxy Materials and Voting Information
1.
What is included in the proxy materials? What is a proxy statement and what is a proxy?
   
The proxy materials for our 2024 Annual Meeting include the Notice Regarding the Availability of Proxy Materials, Notice of 2024 Annual Meeting, this Proxy Statement and our Annual Report for the fiscal year ended December 31, 2023 (collectively, the “proxy materials”). If you request a paper copy of these materials, the proxy materials will also include a proxy card or voting instruction form.
A proxy statement is a document that SEC regulations require us to give you when we ask you to return a proxy designating individuals to vote on your behalf. A proxy is your legal designation of another person to vote the shares you own. That other person is called your proxy.
2.
What is the difference between holding shares as a shareholder of record and as a beneficial owner?
   
If your shares are registered directly in your name with our registrar and transfer agent, Equiniti Shareowner Services, you are considered a shareholder of record of those shares. If you are a shareholder of record, you should receive only one notice or proxy card for all the Common Shares you hold, whether in certificate or book entry form.
If your shares are held in an account you own at a bank or brokerage firm or you hold shares through another nominee, you are considered the “beneficial owner” of those shares. If you are a beneficial owner, you will receive voting instruction information from the bank, broker or other nominee through which you own your Common Shares.
If you hold some shares of record and some shares beneficially, you should receive a notice or proxy card for all the Common Shares you hold of record and a separate voting instruction form for the shares from the bank, broker or other nominee through which you own Common Shares.
3.
What different methods can I use to vote?
   
By Telephone or Internet. All shareholders of record as of the close of business on March 22, 2024, the Record Date, can authorize a proxy to vote their shares by touchtone telephone by calling 1-800-690-6903, or through the internet at www.proxyvote.com, using the procedures and instructions described in your Notice Regarding the Availability of Proxy Materials or proxy card. Beneficial owners may authorize a proxy by telephone or internet if their bank, broker or other nominee makes those methods available, in which case the bank, broker or nominee will include the instructions with the proxy voting materials. To authorize a proxy by telephone or internet, you will need the 16 digit control number provided on your Notice Regarding the Availability of Proxy Materials, proxy card or voting instruction form. The telephone and internet proxy authorization procedures are designed to authenticate shareholder identities, to allow shareholders to authorize a proxy to vote their shares and to confirm that their instructions have been recorded properly. Proxies submitted by telephone or through the internet must be received by 11:59 p.m., Eastern time, on May 30, 2024 or, if the meeting is postponed or adjourned to a later date, by 11:59 p.m., Eastern time, on the day immediately preceding the date of the reconvened meeting.
By Written Proxy. All shareholders of record as of the close of business on the Record Date also can submit voting instructions by written proxy card. If you are a shareholder of record and receive a Notice Regarding the Availability of Proxy Materials, you may request a written proxy card by following the instructions included in the notice. If you are a beneficial owner, you may request a written proxy card or a voting instruction form from your bank, broker or other nominee. Proxies submitted by mail must be received by 11:59 p.m., Eastern time, on May 30, 2024 or, if the meeting is postponed or adjourned to a later date, by 11:59 p.m., Eastern time, on the day immediately preceding the date of the reconvened meeting.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
57

TABLE OF CONTENTS
Electronically at our 2024 Annual Meeting.

All shareholders of record as of the close of business on the Record Date may vote electronically at the meeting, as described in the response to question 11. Even if you plan to attend our 2024 Annual Meeting, we recommend that you follow the voting directions described above, so that your vote will be counted if you later decide not to attend our 2024 Annual Meeting.

Beneficial owners as of the close of business on the Record Date may vote electronically at our 2024 Annual Meeting if they have a 16 digit control number, as described in the response to questions 11 and 12.
A shareholder may revoke a proxy at any time before it is exercised at our 2024 Annual Meeting, subject to the proxy voting deadlines described above, by authorizing a proxy again on a later date by internet or by telephone, by signing and returning a later dated proxy card, by attending the meeting and voting electronically or by sending an original written statement revoking the prior proxy to our Secretary at our principal executive office (or by hand delivery to the Secretary before the taking of the vote at our 2024 Annual Meeting). Attendance at our 2024 Annual Meeting will not, by itself, revoke a duly executed proxy.
Beneficial owners who wish to change their votes should contact the organization that holds their shares.
Shareholders must register in advance to attend our 2024 Annual Meeting by visiting www.proxyvote.com.
If you have any questions or need assistance in voting your shares or authorizing your proxy, please call the firm assisting us in the solicitation of proxies:
D.F. King & Co., Inc.
48 Wall Street, 22
nd Floor
New York, NY 10005
Shareholders: (800) 967-5074
Brokers: (212) 269-5550
4.
Who may vote at our 2024 Annual Meeting?
   
Holders of record of Common Shares as of the close of business on the Record Date, or their duly authorized proxies may vote at the meeting. Holders of Common Shares are entitled to one vote for each Common Share held on the Record Date.
5.
What if I authorize a proxy and do not specify how my shares are to be voted?
   
If you submit a signed proxy card or authorize a proxy by internet or telephone, but do not indicate how your Common Shares should be voted on one or more proposals, then the proxies will vote your shares as our Board recommends on those proposals. Other than the proposals listed on pages 24, 41 and 54 we do not know of any other matters to be presented at the meeting. If any other matters are properly presented at the meeting, the proxies may vote your shares in accordance with their discretion.
6.
What is a quorum? How are abstentions, withheld votes and broker non-votes counted?
   
A quorum of shareholders is required for shareholders to take action at our 2024 Annual Meeting. The presence, in person or by proxy, of shareholders entitled to cast a majority of all the votes entitled to be cast at our 2024 Annual Meeting constitutes a quorum.
Abstentions and broker non-votes (i.e., shares held by brokers or nominees as to which (i) instructions have not been received from the beneficial owner or the persons entitled to vote and (ii) the broker does not have discretionary voting power on a particular matter), if any, are included in determining whether a quorum is present. Abstentions are not votes cast and, therefore, will not be included in vote totals and will have no effect on the outcome of any Proposal to be acted upon at the 2024 Annual Meeting. Broker non-votes are not
 
58
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
votes cast and, therefore, will not be included in vote totals and will have no effect on the outcome of Proposal 1 or 2. There can be no broker non-votes on Proposal 3 as it is a matter on which, if you hold your shares in street name and do not provide voting instructions to the broker, bank or other nominee that holds your shares, the nominee has discretionary authority to vote on your behalf.
With respect to Proposal 1, a proxy marked “WITHHOLD” will have the same effect as an abstention and will not be counted for purposes of determining a plurality of votes cast, but will be counted as a vote “AGAINST” for purposes of determining a majority of votes cast under the Company’s Trustee resignation policy. Pursuant to the Company’s Governance Guidelines, if a Trustee nominee fails to receive a majority of votes cast, he or she will offer to resign from our Board, and our Board will decide whether to accept or reject the resignation offer.
7.
Can I access the proxy materials on the internet? How can I sign up for the electronic proxy delivery service?
   
The Notice of 2024 Annual Meeting, this Proxy Statement and the Annual Report are available at www.proxyvote.com. You may access these proxy materials on the internet through the conclusion of our 2024 Annual Meeting.
Instead of receiving future copies of our proxy materials by mail, shareholders of record, as of the close of business on the Record Date, and most beneficial owners may elect to receive these materials electronically. Opting to receive your future proxy materials electronically will reduce the environmental impact of our annual meeting, save us the cost of printing and mailing documents, and also will give you an electronic link to our proxy voting site. Your Notice Regarding the Availability of Proxy Materials instructs you as to how you may request electronic delivery of future proxy materials.
8.
How are proxies solicited and what is the cost?
   
We bear all expenses incurred in connection with the solicitation of proxies on behalf of the Company. We have engaged D.F. King & Co., Inc. (“D.F. King”) to assist with the solicitation of proxies for an estimated fee of $12,500 plus reimbursement of expenses. We have agreed to indemnify D.F. King against certain liabilities arising out of our agreement with D.F. King. We will request banks, brokers and other nominees to forward proxy materials to the beneficial owners of Common Shares and to obtain their voting instructions. We will reimburse those firms for their expenses of forwarding proxy materials.
Proxies may also be solicited, without additional compensation, by our Trustees and officers, and by RMR, its officers and employees and its parent’s and subsidiaries’ directors, trustees, officers and employees, by mail, telephone or other electronic means or in person.
9.
What is householding?
   
As permitted by the Exchange Act and our Bylaws, we may deliver to shareholders only one copy of the Notice Regarding the Availability of Proxy Materials, Notice of 2024 Annual Meeting, this Proxy Statement and the Annual Report to Shareholders residing at the same address, unless a shareholder at such address has notified us of such shareholder’s desire to receive separate copies of those documents. This practice is known as “householding.”
We will deliver a separate copy of any of those documents to you if you write to us at Investor Relations, Diversified Healthcare Trust, Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458, or call us at (617) 796-8234. If you want to receive separate copies of our notices regarding the availability of proxy materials, notices of annual meetings, proxy statements and annual reports in the future, or if you are receiving multiple copies and would like to receive only one copy per household, you should contact your bank, broker or other nominee, or you may contact us at the above address or telephone number.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
59

TABLE OF CONTENTS
2024 Annual Meeting Information
10.
Why is our 2024 Annual Meeting being held virtually?
   
To provide all of our shareholders an opportunity to participate in our 2024 Annual Meeting, our 2024 Annual Meeting will be a completely virtual meeting of shareholders. Shareholders attending our 2024 Annual Meeting virtually will be afforded the same rights and opportunities to participate as they would have had at an in-person meeting.
11.
How do I attend our virtual 2024 Annual Meeting?
   
In order to attend and participate in our 2024 Annual Meeting, shareholders must register in advance at www.proxyvote.com by 11:59 p.m. Eastern time, on May 30, 2024. Attendance at the meeting is limited to our Trustees and officers, shareholders as of the close of business on the Record Date or their duly authorized representatives or proxies, and other persons permitted by the chair of the meeting.

Record owners: If you are a shareholder as of the close of business on the Record Date who holds shares directly, you may participate in our 2024 Annual Meeting by visiting https://www.virtualshareholdermeeting.com/DHC2024 and entering the 16 digit control number located on your Notice Regarding the Availability of Proxy Materials or proxy card.

Beneficial owners: If you are a shareholder as of the close of business on the Record Date who holds shares indirectly through a brokerage firm, bank or other nominee, you may participate in our 2024 Annual Meeting by visiting https://www.virtualshareholdermeeting.com/DHC2024 and entering the 16 digit control number located on your Notice Regarding the Availability of Proxy Materials, proxy card or voting instruction form. Please follow the instructions from your bank, broker or nominee included with these proxy materials, or contact your bank, broker or nominee to request a control number if needed.
If you have questions regarding preregistration procedures or admission procedures, please call Investor Relations at (617) 796-8234.
12.
How can I vote electronically at our 2024 Annual Meeting if I am a beneficial owner?
   
If you are a beneficial owner and want to vote your shares at our 2024 Annual Meeting, you need to have a 16 digit control number from your bank, broker or other nominee. Please follow the procedures described in the response to questions 3 and 11.
You will not be able to vote your shares at the meeting without a 16 digit control number. We encourage you to vote your shares in advance, even if you intend to attend the meeting.
13.
How can I ask questions at our 2024 Annual Meeting?
   
Shareholders as of the close of business on the Record Date who attend and participate in our 2024 Annual Meeting at https://www.virtualshareholdermeeting.com/DHC2024 will have an opportunity to submit questions live via the internet during a designated portion of the program. Shareholders must have available their control number provided on their proxy card or voting instruction form.
If you experience any technical difficulties accessing our 2024 Annual Meeting or during the meeting, please call the toll-free number that will be available on our virtual shareholder login site for assistance. We will have technicians ready to assist you with any technical difficulties you may have beginning 15 minutes prior to the start of our 2024 Annual Meeting.
 
60
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
Company Documents, Communications and Shareholder Proposals
14.
How can I view or request copies of our SEC filings and other documents?
   
You can visit our website to view our Governance Guidelines, Board committee charters and the Code. To view these documents, go to www.dhcreit.com, click on “Investors” and then click on “Governance.” To view our SEC filings and Forms 3, 4 and 5 filed by our Trustees and executive officers, go to www.dhcreit.com, click on “Investors,” click on “Financial Information” and then click on “SEC Filings.”
We will deliver free of charge, upon request, a copy of our Governance Guidelines, Board committee charters, Code or Annual Report to any shareholder requesting a copy. Requests should be directed to Investor Relations at Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458.
15.
How can I communicate with our Trustees?
   
Any shareholder or other interested person who wants to communicate with our Trustees should write to such Trustee(s), c/o Secretary, Diversified Healthcare Trust, Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458 or email secretary@dhcreit.com. The communication will then be delivered to the Trustee(s).
16.
How do I submit a nomination or other proposal for action at the 2025 annual meeting of shareholders?
   
A nomination or other proposal for action to be presented by any shareholder at our 2025 annual meeting of shareholders must be submitted as follows:

For a proposal to be eligible to be included in the proxy statement pursuant to Rule 14a-8 under the Exchange Act, the proposal must be received at our principal executive office by November 26, 2024.

If the shareholder nomination is to be included in the proxy statement pursuant to our proxy access bylaw, the nomination must be made in accordance with the procedures and requirements set forth in our Bylaws and must be delivered to or mailed and received by us not later than November 26, 2024 and not earlier than October 27, 2024.

If the shareholder nomination or proposal is not to be included in the proxy statement pursuant to our proxy access bylaw or Rule 14a-8, the nomination or proposal must be made in accordance with the procedures and requirements set forth in our Bylaws and must be delivered to us not later than 5:00 p.m., Eastern time, on November 26, 2024 and not earlier than October 27, 2024.
Proposals should be sent to our Secretary at Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts 02458.
For additional information regarding how to submit a shareholder proposal, see page 22 of this Proxy Statement.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
61

TABLE OF CONTENTS
RELATED PERSON TRANSACTIONS
The descriptions of agreements in this “Related Person Transactions” section do not purport to be complete and are subject to, and qualified in their entirety by, reference to the actual agreements, copies of certain of which are filed as exhibits to the Annual Report.
A “related person transaction” is a transaction, arrangement or relationship (or any series of similar transactions, arrangements or relationships) in which (i) we were, are or will be a participant, (ii) the amount involved exceeds $120,000 and (iii) any related person had, has or will have a direct or indirect material interest.
A “related person” means any person who is, or at any time since January 1, 2023 was:

a Trustee, a nominee for Trustee or an executive officer of ours;

known to us to be the beneficial owner of more than 5.0% of the outstanding Common Shares when a transaction in which such person had a direct or indirect material interest occurred or existed;

an immediate family member of any of the persons referenced in the preceding two bullets, which means any child, stepchild, parent, stepparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law or sister-in-law of any of the persons referenced in the preceding two bullets, and any person (other than a tenant or employee) sharing the household of any of the persons referenced in the preceding two bullets; or

a firm, corporation or other entity in which any of the foregoing persons is a partner or principal or in a similar position or in which such person has a 10.0% or greater beneficial ownership interest.
We have adopted written Governance Guidelines that describe the consideration and approval of related person transactions. Under these Governance Guidelines, we may not enter into a transaction in which any Trustee or executive officer, any member of the immediate family of any Trustee or executive officer or other related person, has or will have a direct or indirect material interest unless that transaction has been disclosed or made known to our Board and our Board reviews and approves or ratifies the transaction by the affirmative vote of a majority of the disinterested Trustees, even if the disinterested Trustees constitute less than a quorum. If there are no disinterested Trustees, the transaction must be reviewed, authorized and approved or ratified by both (i) the affirmative vote of a majority of our Board and (ii) the affirmative vote of a majority of the Independent Trustees. In determining whether to approve or ratify a transaction, our Board, or disinterested Trustees or Independent Trustees, as the case may be, also act in accordance with any applicable provisions of our Declaration of Trust and Bylaws, consider all of the relevant facts and circumstances and approve only those transactions that they determine are fair and reasonable to us. All related person transactions described in Annex A to this Proxy Statement were reviewed and approved or ratified by a majority of the disinterested Trustees or otherwise in accordance with our policies, Declaration of Trust and Bylaws, each as described above, and Maryland law. In the case of any transactions with us by employees of RMR and its subsidiaries who are subject to the Code but who are not our Trustees or executive officers, the employee must seek approval from an executive officer who has no interest in the matter for which approval is being requested. Copies of our Governance Guidelines and the Code are available on our website, www.dhcreit.com.
Certain related person transactions are set forth in Annex A to this Proxy Statement.
 
62
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
OTHER INFORMATION
At this time, we know of no other matters that will be brought before the meeting. If, however, other matters properly come before the meeting or any postponement or adjournment, the persons named in the accompanying proxy card intend to vote the shares for which they have been appointed or authorized as proxy in accordance with their discretion on such matters to the maximum extent that they are permitted to do so by applicable law.
Jennifer B. Clark
Secretary
Newton, Massachusetts
March 26, 2024
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
63

TABLE OF CONTENTS
ANNEX A—CERTAIN RELATED PERSON TRANSACTIONS
Relationships with AlerisLife, RMR, RMR Inc. and Others Related to Them. We have relationships and historical and continuing transactions with AlerisLife, RMR, RMR Inc., and others related to them, including other RMR Clients and some of which have trustees, directors or officers who are also our Trustees or officers. RMR Inc. is the managing member of RMR. The Chair of our Board and one of our Managing Trustees, Adam D. Portnoy, is the sole trustee, an officer and the controlling shareholder of ABP Trust, which is the controlling shareholder of RMR Inc., chair of the board of directors, a managing director and the president and chief executive officer of RMR Inc., an officer and employee of RMR and, prior to March 20, 2023, was the chair of the board and a managing director of AlerisLife and since that time is AlerisLife’s sole director. Jennifer F. Francis, our other Managing Trustee and our former President and Chief Executive Officer, was an executive vice president of RMR and is an employee of RMR, and Richard W. Siedel, Jr., our former Chief Financial Officer and Treasurer, was also an officer of RMR and is an employee of RMR. Our current executive officers are officers and employees of RMR. Jennifer B. Clark, our Secretary and former Managing Trustee, also serves as a managing director and the executive vice president, general counsel and secretary of RMR Inc., an officer and employee of RMR, an officer of ABP Trust, secretary of AlerisLife and, prior to March 20, 2023, was a managing director of AlerisLife. RMR provides management services to us and AlerisLife.
Some of our Independent Trustees also serve as independent trustees of other public RMR Clients. Mr. Portnoy serves as the chair of the boards of trustees and as a managing trustee of each of these public companies. Other officers of RMR, including Ms. Clark, serve as managing trustees, or officers of certain of these companies. In addition, officers of RMR and RMR Inc. serve as our officers and officers of other companies to which RMR provide management services.
AlerisLife. Until March 20, 2023, we were AlerisLife’s largest stockholder, owning approximately 31.9% of AlerisLife’s outstanding common shares, and ABP Trust and its subsidiary owned approximately 6.1% of AlerisLife’s outstanding common shares.
On February 2, 2023, AlerisLife entered into an Agreement and Plan of Merger, (the “ALR Merger Agreement”) with certain subsidiaries of ABP Trust, pursuant to which ABP Trust acquired all of the publicly held outstanding AlerisLife common shares at a price of $1.31 per share by tender offer (the “Tender Offer Price”). In connection with the ALR Merger Agreement, on February 2, 2023, we agreed to tender all the AlerisLife common shares that we and our subsidiary then owned into the tender offer at the Tender Offer Price, subject to the right, but not the obligation, to purchase, on or before December 31, 2023, AlerisLife common shares at the Tender Offer Price, and otherwise pursuant to a stockholders agreement to be entered into at the time of any such purchase. On December 20, 2023, we and ABP Trust extended our right to purchase AlerisLife common shares until March 31, 2024. On February 16, 2024, we exercised this purchase right and acquired, together with our applicable taxable REIT subsidiary, approximately 34.0% of the currently outstanding AlerisLife common shares from ABP Trust at the Tender Offer Price, for a total purchase price of $14.9 million, and we, our applicable taxable REIT subsidiary, ABP Trust and Aleris Life entered into a stockholders agreement. Following this acquisition, ABP Trust owns the remaining approximate 66.0% of AlerisLife.
Management Arrangements with Five Star. Five Star is an operating division of AlerisLife. Five Star manages certain of the senior living communities we own pursuant to an amended and restated Master Management Agreement (the “Master Management Agreement”). We lease our senior living communities that are managed by Five Star to our taxable REIT subsidiaries. As of December 31, 2023, Five Star managed 119 of our senior living communities.
Pursuant to the Master Management Agreement, Five Star receives a management fee equal to 5% of the gross revenues realized at the applicable senior living communities plus reimbursement for its direct costs and expenses related to such communities. Five Star may receive an annual incentive fee equal to 15% of the amount by which the annual earnings before interest, taxes, depreciation and amortization, (“EBITDA”), of all communities on a combined basis exceeds the target EBITDA for all communities on a combined basis for such calendar year. The target EBITDA for those communities on a combined basis is increased annually based on the greater of the annual increase of the consumer price index, (“CPI”), or 2%, plus 6% of any capital investments funded at the managed communities on a combined basis in excess of the target capital
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
A-1

TABLE OF CONTENTS
investment. Unless otherwise agreed, the target capital investment increases annually based on the greater of the annual increase of CPI or 2%. Any senior living communities that are undergoing a major renovation or repositioning are excluded from the calculation of the incentive fee.
The Master Management Agreement expires in 2036, subject to Five Star’s right to extend for two consecutive five year terms if Five Star achieves certain performance targets for the combined managed communities portfolio, unless earlier terminated. Pursuant to the Master Management Agreement, beginning in 2025, we have the right to terminate up to 10% of the senior living communities that Five Star is continuing to manage, based on total revenues per year for failure to meet 80% of a target EBITDA for the applicable period. Pursuant to a guaranty agreement made by AlerisLife in favor of our applicable subsidiaries, AlerisLife has guaranteed the payment and performance of each of its applicable subsidiary’s obligations under the Master Management Agreement.
In connection with ABP Trust’s acquisition of AlerisLife on March 20, 2023, we amended the Master Management Agreement to eliminate any change of control default or event of default provisions.
We incurred management fees payable to Five Star of approximately $40.1 million for the year ended December 31, 2023.
In addition to providing management services to us, Five Star also provides certain other services to residents at some of the senior living communities it manages for us, such as rehabilitation services. At senior living communities Five Star manages for us where Five Star provides rehabilitation services on an outpatient basis, the residents, third party payers or government programs pay Five Star for those rehabilitation services. At senior living communities Five Star manages for us where Five Star provides both inpatient and outpatient rehabilitation services, we generally pay Five Star for those rehabilitation services and charges for these services are included in amounts charged to residents, third party payers or government programs. During 2023, Five Star closed all inpatient clinics and as such, we do not expect to incur these fees to Five Star in the future. We incurred fees of approximately $1.2 million for the year ended December 31, 2023 with respect to rehabilitation services Five Star provided at senior living communities that are payable by us.
We lease to Five Star space at certain of our senior living communities, which it uses to provide certain outpatient rehabilitation and wellness services. We recognized $1.4 million of rent for the year ended December 31, 2023 in connection with these lease arrangements.
AlerisLife participated in our property insurance program for the senior living communities AlerisLife owns and leases. The premiums AlerisLife paid for this coverage were allocated pursuant to a formula based on the profiles of the properties included in the program. AlerisLife’s program cost for the policy year ending June 30, 2023 was $0.4 million. AlerisLife procured its own property insurance policy for its senior living communities starting with the policy year beginning on July 1, 2023.
RMR. We have no employees. The personnel and various services we require to operate our business are provided to us by RMR. We have two agreements with RMR to provide management services to us: (i) a business management agreement, which relates to our business generally, and (ii) a property management agreement, which relates to the property level operations of many of our properties, including our medical office and life science properties, and major renovation or repositioning activities at our senior living communities that we may request RMR to manage from time to time. Both of these agreements are described below, see “—Management Agreements with RMR.”
Management Agreements with RMR. Our management agreements with RMR provide for an annual base management fee, an annual incentive management fee and property management and construction supervision fees, payable in cash, among other terms:

Base Management Fee. The annual base management fee payable to RMR by us for each applicable period is equal to the lesser of:

the sum of (a) 0.5% of the daily weighted average of the aggregate book value of our real estate assets owned by us or our subsidiaries as of October 12, 1999 (the “Transferred Assets”), plus (b) 0.7% of the average aggregate historical cost of our real estate investments excluding the Transferred Assets up to $250.0 million, plus (c) 0.5% of the average aggregate historical cost of our real estate investments excluding the Transferred Assets exceeding $250.0 million; and
 
A-2
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS

the sum of (a) 0.7% of the average closing price per Common Share on the stock exchange on which such Common Shares are principally traded during such period, multiplied by the average number of Common Shares outstanding during such period, plus the daily weighted average of the aggregate liquidation preference of each class of our preferred shares outstanding during such period, plus the daily weighted average of the aggregate principal amount of our consolidated indebtedness during such period (together, the “Company’s Average Market Capitalization”), up to $250.0 million, plus (b) 0.5% of the Company’s Average Market Capitalization exceeding $250.0 million.
The average aggregate historical cost of our real estate investments includes our consolidated assets invested, directly or indirectly, in equity interests in or loans secured by real estate and personal property owned in connection with such real estate (including acquisition related costs and costs which may be allocated to intangibles or are unallocated), all before reserves for depreciation, amortization, impairment charges or bad debts or other similar non-cash reserves.

Incentive Management Fee. The incentive management fee which may be earned by RMR for an annual period is calculated as follows:

An amount, subject to a cap, based on the value of the outstanding Common Shares, equal to 12.0% of the product of:

our equity market capitalization on the last trading day of the year immediately prior to the relevant three year measurement period, and

the amount (expressed as a percentage) by which the total return per share, as defined in the business management agreement and further described below, of the holders of Common Shares (i.e., share price appreciation plus dividends) exceeds the total shareholder return of the applicable market index, or the benchmark return per share, for the relevant measurement period. The MSCI U.S. REIT/Health Care REIT Index is the benchmark index for periods beginning on and after August 1, 2021, and the SNL U.S. REIT Healthcare Index is the benchmark index for periods prior to August 1, 2021.
For purposes of the total return per share of the holders of Common Shares, share price appreciation for a measurement period is determined by subtracting (1) the closing price of the Common Shares on the Nasdaq on the last trading day of the year immediately before the first year of the applicable measurement period, or the initial share price, from (2) the average closing price of the Common Shares on the 10 consecutive trading days having the highest average closing prices during the final 30 trading days in the last year of the measurement period.

The calculation of the incentive management fee (including the determinations of our equity market capitalization, initial share price and the total return per share of holders of Common Shares) is subject to adjustments if we issue or repurchase our Common Shares, or if our Common Shares are forfeited, during the measurement period.

No incentive management fee is payable by us unless the total return per share during the measurement period is positive.

The measurement periods are three year periods ending with the year for which the incentive management fee is being calculated.

If our total return per share exceeds 12.0% per year in any measurement period, the benchmark return per share is adjusted to be the lesser of the total shareholder return of the applicable market index for such measurement period and 12.0% per year, or the adjusted benchmark return per share. In instances where the adjusted benchmark return per share applies, the incentive management fee will be reduced if our total return per share is between 200 basis points and 500 basis points below the applicable market index in any year, by a low return factor, as defined in the business management agreement, and there will be no incentive management fee paid if, in these instances, our total return per share is more than 500 basis points below the applicable market index, determined on a cumulative basis (i.e., between 200 basis points and 500 basis points per year multiplied by the number of years in the measurement period and below the applicable market index).

The incentive management fee is subject to a cap. The cap is equal to the value of the number of Common Shares which would, after issuance, represent 1.5% of the number of Common
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
A-3

TABLE OF CONTENTS
Shares then outstanding multiplied by the average closing price of Common Shares during the 10 consecutive trading days having the highest average closing prices during the final 30 trading days of the relevant measurement period.

Incentive management fees we paid to RMR for any period may be subject to “clawback” if our financial statements for that period are restated due to material non-compliance with any financial reporting requirements under the securities laws as a result of the bad faith, fraud, willful misconduct or gross negligence of RMR and the amount of the incentive management fee we paid was greater than the amount we would have paid based on the restated financial statements.
Pursuant to our business management agreement with RMR, we recognized net business management fees of approximately $14.0 million for the year ended December 31, 2023, which amount reflects a reduction of approximately $3.0 million for the amortization of the liability we recorded in accordance with generally accepted accounting principles in connection with our former investment in RMR Inc. in June 2015.
We did not recognize an incentive management fee payable to RMR for the year ended December 31, 2023. In calculating the incentive management fee payable by us, our total shareholder return per share2 and benchmark return per share were adjusted in accordance with our business management agreement to reflect aggregate net increases in the number of Common Shares outstanding as a result of certain share issuances, repurchases and forfeitures by us during the three year measurement period ended December 31, 2023.

Property Management and Construction Supervision Fees. The property management fees payable to RMR by us for each applicable period are equal to 3.0% of gross collected rents and the construction supervision fees payable to RMR by us for each applicable period are equal to 5.0% of construction costs. Our property management agreement provides for RMR’s oversight of any major capital projects and repositionings at our senior living communities, including our senior living communities that Five Star manages. RMR will receive the same fee we pay to Five Star for capital projects it oversees at our senior living communities it manages, which is equal to 3.0% of the cost of any such major capital project or repositioning.
Pursuant to our property management agreement with RMR, we recognized aggregate net property management and construction supervision fees of approximately $8.9 million for the year ended December 31, 2023, which amount reflects a reduction of approximately $0.8 million for the amortization of the liability we recorded in accordance with generally accepted accounting principles in connection with our former investment in RMR Inc. in June 2015.

Expense Reimbursement. We are generally responsible for all our operating expenses, including certain expenses incurred or arranged by RMR on our behalf. We are generally not responsible for payment of RMR’s employment, office or administrative expenses incurred to provide management services to us, except for the employment and related expenses of RMR’s employees assigned to work exclusively or partly at our medical office and life science properties, our share of the wages, benefits and other related costs of RMR’s centralized accounting personnel, our share of RMR’s costs for providing our internal audit function, or as otherwise agreed. Our property level operating expenses are generally incorporated into rents charged to our tenants, including certain payroll and related costs incurred by RMR. We reimbursed RMR approximately $14.6 million for these expenses and costs for the year ended December 31, 2023.

Term. Our management agreements with RMR have terms that end on December 31, 2043, and automatically extend on December 31st of each year for an additional year, so that the terms of our management agreements thereafter end on the 20th anniversary of the date of the extension.

Termination Rights. We have the right to terminate one or both of our management agreements with RMR: (i) at any time on 60 days’ written notice for convenience, (ii) immediately on written notice
2
“Total shareholder return” for purposes of the incentive management fee calculation differs from “total shareholder return” presented in the performance graph in the Annual Report because “total shareholder return” for purposes of the incentive management fee calculation has been determined in accordance with the terms of the business management agreement and includes adjustments for Common Shares issued, repurchased and forfeited during the period and other items whereas “total shareholder return” presented in the performance graph is determined in the same or similar manner as each index reflected in the performance graph and does not include such adjustments and other items.
 
A-4
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
for cause, as defined therein, (iii) on written notice given within 60 days after the end of an applicable calendar year for a performance reason, as defined therein, and (iv) by written notice during the 12 months following a change of control of RMR, as defined therein. RMR has the right to terminate the management agreements for good reason, as defined therein.

Termination Fee. If we terminate one or both of our management agreements with RMR for convenience, or if RMR terminates one or both of our management agreements for good reason, we have agreed to pay RMR a termination fee in an amount equal to the sum of the present values of the monthly future fees, as defined therein, for the terminated management agreement(s) for the term that was remaining prior to such termination, which, depending on the time of termination would be between 19 and 20 years. If we terminate one or both of our management agreements with RMR for a performance reason, we have agreed to pay RMR the termination fee calculated as described above, but assuming a 10 year term was remaining prior to the termination. We are not required to pay any termination fee if we terminate our management agreements with RMR for cause or as a result of a change of control of RMR.

Transition Services. RMR has agreed to provide certain transition services to us for 120 days following an applicable termination by us or notice of termination by RMR, including cooperating with us and using commercially reasonable efforts to facilitate the orderly transfer of the management and real estate investment services provided under our business management agreement and to facilitate the orderly transfer of the management of the managed properties under our property management agreement, as applicable.

Vendors. Pursuant to our management agreements with RMR, RMR may from time to time negotiate on our behalf with certain third party vendors and suppliers for the procurement of goods and services to us. As part of this arrangement, we may enter agreements with RMR and other RMR Clients for the purpose of obtaining more favorable terms from such vendors and suppliers.

Investment Opportunities. Under our business management agreement with RMR, we acknowledge that RMR may engage in other activities or businesses and act as the manager to any other person or entity (including other REITs) even though such person or entity has investment policies and objectives similar to ours and we are not entitled to preferential treatment in receiving information, recommendations and other services from RMR.
Our Joint Ventures. We have two separate joint venture arrangements with third party institutional investors, one for a life science property located in Boston, Massachusetts (the “Seaport JV”) and another for 10 medical office and life science properties (the “LSMD JV”). We own a 10% equity interest in the Seaport JV and a 20% equity interest in the LSMD JV. RMR provides management services to both of these joint ventures. Our joint ventures are not our consolidated subsidiaries and, as a result, we are not obligated to pay management fees to RMR under our management agreements with RMR for the services it provides regarding the joint ventures.
Termination of the Merger Agreement with Office Properties Income Trust. On April 11, 2023, we and OPI entered into an Agreement and Plan of Merger, (the “Merger Agreement”), pursuant to which we would merge with OPI, with OPI as the surviving entity in the merger. On September 1, 2023, we and OPI mutually terminated the Merger Agreement. Neither we nor OPI were required to pay any termination fee as a result of the mutual decision to terminate the Merger Agreement, and we and OPI bore our respective costs and expenses related to the Merger Agreement in accordance with the terms of the Merger Agreement.
Share Awards to RMR Employees. We award Common Shares to our officers and other employees of RMR annually. Generally, one fifth of these awards vests on the date of the awards and one fifth vests on each of the next four anniversaries of the dates of the awards. During 2023, we awarded to certain of our officers and other employees of RMR annual awards of 800,000 Common Shares, valued at approximately $1.9 million, in aggregate, based upon the closing price of the Common Shares on the Nasdaq on the date the awards were made under our equity compensation plan. These share awards to RMR employees are in addition to the share awards made to our Managing Trustees, as Trustee compensation, and the fees we paid to RMR. During 2023, we purchased 184,344 Common Shares, at the closing price of the Common Shares on the Nasdaq on the date of purchase, from certain of our officers and other employees of RMR in satisfaction of tax withholding and payment obligations in connection with the vesting of awards of the Common Shares.
 
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement
A-5

TABLE OF CONTENTS
On occasion, we have entered into arrangements with former employees of RMR in connection with the termination of their employment with RMR, providing for the acceleration of vesting of Common Share awards previously awarded to them under our equity compensation plans. The aggregate value of the Common Share awards we so accelerated, measured as of the effective dates of acceleration, was approximately $0.3 million, in aggregate, for the year ended December 31, 2023. Additionally, certain of our executive officers during 2023 received share awards of RMR Inc. and other RMR Clients in their capacities as officers or employees of RMR.
Leases with RMR. We lease office space to RMR in certain of our properties for RMR’s property management offices. Pursuant to our lease agreements with RMR, we recognized rental income from RMR for leased office space of approximately $0.2 million for the year ended December 31, 2023. Our office space leases with RMR are terminable by RMR if our management agreements with RMR are terminated.
Directors’ and Officers’ Liability Insurance. We, RMR Inc. and certain other RMR Clients participate in a combined directors’ and officers’ liability insurance policy. We paid a premium of $0.1 million for this coverage for the policy years ending September 30, 2023, 2024 and 2025.
The foregoing descriptions of our agreements with RMR Inc., RMR, AlerisLife, including Five Star, and other related persons are summaries and are qualified in their entirety by the terms of the agreements. A further description of the terms of certain of those agreements is included in the Annual Report. In addition, copies of certain of the agreements evidencing these relationships are filed with the SEC and may be obtained from the SEC’s website, www.sec.gov. We may engage in additional transactions with related persons, including businesses to which RMR provides management services.
 
A-6
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
2024 Proxy Statement

TABLE OF CONTENTS
   
[MISSING IMAGE: lg_divershealthtrust-pn.jpg]
THANK YOU
Thank you for being a shareholder of Diversified Healthcare Trust.

TABLE OF CONTENTS
[MISSING IMAGE: px_24proxy1pg1-bw.jpg]
INVESTOR RELATIONSDIVERSIFIED HEALTHCARE TRUST255 WASHINGTON STREET, SUITE 300NEWTON, MASSACHUSETTS 02458AUTHORIZE YOUR PROXY BY INTERNETBefore the meeting - Go to www.proxyvote.com or scan the QR Barcode aboveUse the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m.,Eastern Time, on May 30, 2024. Have your proxy card in hand when you access the website and follow the instructionsto obtain your records and to submit your voting instructions.AUTHORIZE YOUR PROXY BY TELEPHONE - 1-800-690-6903Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m., Eastern Time, on May 30, 2024.Have your proxy card in hand when you call and then follow the instructions.If the meeting is postponed or adjourned, the above times will be extended to 11:59 p.m., Eastern Time, on the daybefore the reconvened meeting.AUTHORIZE YOUR PROXY BY MAILMark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it toDiversified Healthcare Trust, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.VOTE BY VIRTUALLY ATTENDING THE MEETINGYou must register in advance to attend the meeting by visiting the "Attend a Meeting" link at www.proxyvote.com.During the meeting - Go to https://www.virtualshareholdermeeting.com/DHC2024You may attend the meeting via the Internet and vote during the meeting. Have your proxy card in hand when youaccess the website and follow the instructions provided on the website.ELECTRONIC DELIVERY OF FUTURE SHAREHOLDER COMMUNICATIONSIf you would like to reduce the costs incurred by Diversified Healthcare Trust in mailing proxy materials, you can consentto receiving all future proxy statements, proxy cards and annual reports electronically by email or over the Internet. Tosign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted,indicate that you agree to receive or access shareholder communications electronically in future years.TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTEDAS DIRECTED OR, IF NO DIRECTION IS GIVEN, WILLBE VOTED FOR ALL THE NOMINEES FOR TRUSTEE INPROPOSAL 1 AND FOR PROPOSALS 2 AND 3.TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLELAW, THE PROXIES, IN THEIR DISCRETION, AREAUTHORIZED TO VOTE AND OTHERWISE REPRESENTTHE UNDERSIGNED ON SUCH OTHER MATTERS AS MAYPROPERLY COME BEFORE THE MEETING OR AT ANYPOSTPONEMENT OR ADJOURNMENT THEREOF.(NOTE: Please sign exactly as your name(s) appear(s) hereon. All holders must sign. When signing as attorney, executor, administrator or other fiduciary, please give full title as such.Joint owners should each sign personally. If a corporation, please sign in full corporate name, by authorized officer, indicating title. If a partnership, please sign in partnership nameby authorized person indicating title.)

TABLE OF CONTENTS
[MISSING IMAGE: px_24proxy1pg2-bw.jpg]
DIVERSIFIED HEALTHCARE TRUSTANNUAL MEETING OF SHAREHOLDERSMay 31, 2024, 9:30 a.m., Eastern TimeDiversified Healthcare TrustVirtually via the Internet athttps://www.virtualshareholdermeeting.com/DHC2024Please see the Proxy Statement for attendance instructions.The 2024 Annual Meeting of Shareholders of Diversified Healthcare Trustwill address the following items of business:1. Election of the Trustees named in the Proxy Statement to the Company's Board of Trustees;2. Advisory vote to approve executive compensation;3. Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2024 fiscal year; and4. Transaction of such other business as may properly come before the meeting and at any postponements or adjournments of the meeting.THE BOARD OF TRUSTEES RECOMMENDS A VOTE FOR ALL THE NOMINEES FOR TRUSTEE IN PROPOSAL 1 AND FOR PROPOSALS 2 AND 3.DIVERSIFIED HEALTHCARE TRUSTANNUAL MEETING OF SHAREHOLDERSMay 31, 2024, 9:30 a.m., Eastern TimeImportant Notice Regarding the Availability of Proxy Materials: The proxy materials for the 2024 Annual Meeting of Shareholders ofDiversified Healthcare Trust (the “Company”), including the Company's annual report and proxy statement, are available on the Internet. To view the proxy materials or authorize your proxy by Internet, by telephone or by mail, please follow the instructions on the reverse side hereof.This proxy is solicited on behalf of the Board of Trustees of Diversified Healthcare Trust.The undersigned shareholder of the Company hereby appoints Jennifer B. Clark and Adam D. Portnoy, or any of them, as proxies for the undersigned, with full power of substitution in each of them, to attend the 2024 Annual Meeting of Shareholders of the Company to be held virtually via the Internet athttps://www.virtualshareholdermeeting.com/DHC2024, on May 31, 2024, at 9:30 a.m., Eastern Time, and any postponement or adjournment thereof, to cast on behalf of the undersigned all the votes that the undersigned is entitled to cast at the meeting and otherwise to represent the undersigned at the meeting with all powers possessed by the undersigned if personally present at the meeting. The undersigned hereby acknowledges receipt of the annual report and the proxy statement, which includes the Notice of 2024 Annual Meeting of Shareholders, each of which is incorporated herein by reference, and revokes any proxy heretofore given with respect to the meeting.THE VOTES ENTITLED TO BE CAST BY THE UNDERSIGNED WILL BE CAST AS INSTRUCTED ON THE REVERSE SIDE HEREOF. IF THIS PROXY IS EXECUTED, BUT NO INSTRUCTION IS GIVEN, THE VOTES ENTITLED TO BE CAST BY THE UNDERSIGNED WILL BE CAST FOR ALL THE NOMINEES FOR TRUSTEE IN PROPOSAL 1 AND FOR PROPOSALS 2 AND 3. ADDITIONALLY, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, THE VOTES ENTITLED TO BE CAST BY THE UNDERSIGNED WILL BE CAST BY THE PROXIES, IN THEIR DISCRETION, ON ANY OTHER MATTER THAT MAY PROPERLY COME BEFORE THE MEETING OR AT ANY POSTPONEMENT OR ADJOURNMENT THEREOF.See reverse for instructions on how to authorize a proxy.

DEF 14A 174600 17475 false 0001075415 0001075415 2023-01-01 2023-12-31 0001075415 2022-01-01 2022-12-31 0001075415 2021-01-01 2021-12-31 0001075415 2020-01-01 2020-12-31 0001075415 dhc:EquityAwardsValueInCompensationTableForTheApplicableYearMember ecd:PeoMember 2023-01-01 2023-12-31 0001075415 dhc:TotalCompensationPerSummaryCompensationTableLessStockGrantAmountMember ecd:PeoMember 2023-01-01 2023-12-31 0001075415 dhc:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember ecd:PeoMember 2023-01-01 2023-12-31 0001075415 dhc:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember ecd:PeoMember 2023-01-01 2023-12-31 0001075415 dhc:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember ecd:PeoMember 2023-01-01 2023-12-31 0001075415 dhc:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember ecd:PeoMember 2023-01-01 2023-12-31 0001075415 dhc:EquityAwardsAdjustmentsMember ecd:PeoMember 2023-01-01 2023-12-31 0001075415 dhc:EquityAwardsValueInCompensationTableForTheApplicableYearMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001075415 dhc:TotalCompensationPerSummaryCompensationTableLessStockGrantAmountMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001075415 dhc:EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001075415 dhc:EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001075415 dhc:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001075415 dhc:EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001075415 dhc:EquityAwardsAdjustmentsMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 iso4217:USD